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Abstract  
 
Proteins secreted by Mycobacterium tuberculosis play an essential role in the 
pathogenesis of tuberculosis. The culture filtrates of M. tuberculosis H37Rv made by 
Sadamu Nagai, Japan, are considerably enriched for secreted proteins compared to 
other culture filtrates. Complementary approaches were used to identify the secreted 
proteins in these culture filtrates: 1) 2D-PAGE combined with MALDI-TOF MS and 2) 
liquid chromatography coupled MS/MS. Peptides derived from a total of 257 proteins 
were identified of which 144 were identified by more than one peptide. Several members 
of the immunologically important Early Secretory Antigenic Target-6 (ESAT-6) family 
of proteins were found to be major components. The majority of the identified proteins, 
159 (62%), were predicted to be exported through the general secretory pathway. We 
experimentally verified that the signal peptides, which mediate translocation through 
the cell membrane, had been removed in 41 of the identified proteins, and in 35 of those, 
there was an AXA motif N-terminally to the cleavage site, showing that this motif is 
important for recognition and cleavage of signal peptides in mycobacteria. A large 
fraction of the secreted proteins were unknowns, suggesting that we have mapped an 
unexplored part of the exported proteome of M. tuberculosis.  
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1 Introduction  
Tuberculosis is a major cause of morbidity and mortality due to a single bacterial pathogen, 
Mycobacterium tuberculosis [1]. According to the WHO, one-third of the world’s population 
is latently infected and there are more than 10 million new cases and 2-3 million deaths 
annually. In 1998, the entire genome of Mycobacterium tuberculosis H37Rv was sequenced 
[2], followed by the genome of the clinical isolate, M. tuberculosis CDC1551 [3] and 
Mycobacterium bovis AF2122/97 [4]. The availability of whole genomic sequences of M. 
tuberculosis complex organisms has greatly facilitated the analysis of its proteome [5-10].  
 
Bacille Calmette-Guerin (BCG) is a live attenuated strain of M. bovis used for vaccination 
[11]. In newborn children, vaccination with BCG prevents miliary and meningeal 
tuberculosis. The efficiency of BCG in preventing pulmonary tuberculosis in adults, which is 
mainly responsible for infectiousness at the community level, is however highly variable and 
in all low [12]. Therefore, there is an urgent need to develop new strategies for combating the 
pathogen. The genomes of the members of the M. tuberculosis complex, including virulent M. 
tuberculosis, M. africanum, M. microti, M. bovis, and attenuated M. bovis BCG are highly 
conserved [13]. Comparative genome analyses have revealed distinct regions in the genome 
of M. tuberculosis H37Rv that have been deleted in wild-type M. bovis, M. bovis BCG 
substrains and/or clinical isolates of M. tuberculosis [11, 14]. In addition, complementary 
proteomic analyses have revealed several differences in the protein composition between M. 
tuberculosis and M. bovis BCG [15, 16]. The consequences of these differences with respect 
to virulence and pathogenesis are still not fully understood. 
 
A significant number of mycobacterial proteins inferred from the genome are predicted to be 
exported. In bacteria, the well-characterized general secretory (Sec) pathway transports 
unfolded proteins across the cytoplasmic membrane to the bacterial envelope and the 
extracellular environment. Proteins targeted to this system contain specific N-terminal signal 
sequences which consist of three distinct regions: the N-, H-, and C- regions. The 
hydrophobic core, also designated the H-region, consists of 10 to 15 amino acid residues. It is 
formed by a stretch of hydrophobic residues that seems to adopt an α-helical conformation in 
the membrane. At the N-terminal side, the H-region is flanked by a positively charged stretch 
of polar residues, the N-region. At the C-terminal side, the H-region is flanked by the C-
region, a stretch of short uncharged polar residues, usually carrying the consensus sequence 
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AXA at position -1 to -3 relative to the cleavage site for Signal peptidase I [17, 18]. Upon 
export, the signal sequence is cleaved by a type I signal peptidase, releasing the mature 
protein at the external side of the cell membrane [19, 20]. 
 
An important feature of M. tuberculosis is its ability to survive and proliferate inside host 
macrophages and to inhibit the acidification and maturation of the phagosome [21-24]. 
Phagosome modification does not take place upon phagocytosis of dead bacilli, suggesting 
that secreted proteins play a key role in pathogenesis [25]. Secreted proteins are also 
considered to be key T-cell antigens of protective immune responses against M. tuberculosis 
[26, 27].  
 
Several attempts have been made to define the secreted proteome of M. tuberculosis. In one 
of the original proteomic studies of M. tuberculosis H37Rv culture filtrate, 8 secreted proteins 
were purified and identified [28]. Relatively few additional proteins with predicted N-terminal 
signal peptide, which can be recognized as secreted through general secretory pathway, have 
been uncovered in subsequent studies by various authors [9, 10, 16, 29-31]. This is probably 
due to considerable contamination of regular culture filtrates with intracellular proteins [32]. 
In the present study we have analysed a unique culture filtrate of M. tuberculosis H37Rv with 
minimal presence of cytoplasmic proteins. By using state of the art proteomic approaches we 
were able to identify 257 proteins, 159 of them had predicted N-terminal signal peptides, out 
of which 25 also had a predicted transmembrane domain in the mature part, and 36 proteins 
were predicted to be lipoproteins. These identifications represents a  major contribution to the 
exploration of the exported proteome of M. tuberculosis which is of great importance in order 
to understand the pathogenesis of tuberculosis. 
 
2 Experimental procedures 
 
2.1 Bacterial cultivation and sample preparation 
M. tuberculosis H37Rv ATCC27294 from the National Institute of Health, Tokyo, Japan was 
cultured as surface pellicle on the wholly synthetic Sauton medium for 3 weeks without  
shaking. Bacteria were removed by filtration and the culture filtrate was concentrated by 80% 
ammonium sulphate precipitation. Precipitated proteins were dissolved in buffer and dialyzed 
against distilled water and lyophilised [28]. Three different batches, referred to as batch A, B 
and C, of the M. tuberculosis H37Rv culture filtrate were analysed to emphasise the 
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reproducibility of the protein profile of the culture filtrate proteins. These preparations were a 
generous gift from Sadamu Nagai, Osaka Japan. 
 
2.2 One-dimensional gel electrophoresis  
Fifty µg of M. tuberculosis H37Rv culture filtrate proteins were mixed with 25 µl sodium-
dedocyl-sulphate (SDS) loading buffer and boiled for 5 minutes prior to separation on a 10 
cm long, 1 mm thick 12% SDS-polyacrylamide (SDS-PAGE) gel. The protein migration was 
allowed to proceed until the blue dye had migrated to the bottom of the gel. The protein bands 
were visualized with Coomassie Brilliant Blue R-250 (CBB) (Bio-Rad, Hercules, CA, USA). 
The molecular mass standard, full-range-rainbow-RPN800 (Amersham Biosciences AB 
Uppsala, Sweden), was used to divide each lane into 10 segments. Each segment was cut into 
smaller pieces, destained, and in-gel digested with trypsin (Promega, Woods Hollow Road, 
Madison, U.S.A.). 
2.3 Two-dimensional gel electrophoresis  
Two mg of M. tuberculosis H37Rv culture filtrate proteins were mixed with 350 µl of 
rehydration buffer (7 M urea, 2 M thiourea, 4% 3-[(3-Cholamidopropyl)Dimethyl-
Ammonio]-1-Propanesulfonate (CHAPS), 2% dithiothreitol (DTT), 2% Immobiline pH 
Gradient buffer (IPG buffer) pH 4-7). Isoelectric focusing was performed at 20°C on 18 cm 
immobiline dry strips (Amersham Biosciences AB, Uppsala, Sweden) with pH intervals (3-
10; 4-5; 4.5-5.5; 5.3-6.5) using Multiphor II Electrophoresis System (Amersham Biosciences 
AB Uppsala, Sweden). Running conditions: Current 2 mA; power 5 W using the EPS 3501 
XL Power Supply in gradient mode and with check option for current turned off. Prior to the 
second dimension, the strips were incubated for 15 minutes in equilibration buffer (6 M urea, 
2% SDS, 0.375 M Tris, pH 8.8, 20% glycerol) with 130 mM DTT first and then with 135 mM 
iodoacetoamide. The equilibrated strip was then placed on an ExcelGel XL SDS 12-14% 
(Amersham Biosciences). The second dimension was run at: current 40 mA and power 40 W 
for 4 hours. Proteins were visualized with CBB. Protein spots were excised from the gel and 
digested with trypsin.  
 
2.4 In-gel digestion 
Sliced gel spots or bands were washed twice with 50% acetonitrile (ACN) in 25 mM 
ammonium bicarbonate (NH4HCO3) for 15 minutes at room temperature (RT). The gel pieces 
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were dehydrated by incubating them with 50 µl 100% ACN for 20 minutes at RT. Proteins 
were reduced using 10 mM DTT and alkylated with 55 mM iodoacetamide (IAA); both in 
100 mM NH4HCO3. The gel pieces were dehydrated with ACN as described above, and 
rehydrated in 25 mmol/l NH4HCO3 containing 0.01 µg/µl modified trypsin (Promega). 
Proteins were digested by trypsin for 16–20 h at 37°C. Then, the tryptic peptides were eluted 
by incubating the gel pieces with 50 µl 1% trifluoroacetic acid (TFA) for 20 minutes at RT. 
The supernatant containing tryptic peptides were collected by centrifugation at 15700 g for 10 
minutes. Additional peptides were extracted from gel pieces by incubation  with 50 µl 0.1% 
TFA in 50% ACN for 20 minutes at RT, followed by centrifugation at 15700 g. The 
supernatant was collected and added to the previous one. Finally, the gel pieces were 
dehydrated by incubating the gel pieces with 50 µl 100% ACN for 20 minutes at RT, and the 
supernatant was collected by centrifugation as described above and added to the pool. 
2.5 In-solution digestion 
Proteins were precipitated from the M. tuberculosis H37Rv culture filtrate by 80% v/v 
acetone at -20ºC over night. The protein pellet obtained after centrifugation at 15700 g for 10 
minutes was dissolved in aqueous 6 M urea (Ultragrade Fluka), 100 mM Tris (Merck) pH 8 
and 10 mM DTT (Amersham Biosciences), and incubated for 1 hour at 37ºC. Iodoacetoamide 
(IAA) was added to a final concentration of 25 mM followed by an one hour incubation in the 
dark at 37ºC. To avoid unwanted protease alkylation, DTT corresponding to 2.5 mM was 
added followed by a 20 minute incubation at 37ºC. The sample volume was diluted 1:3 with 
MilliQ water (Sigma), and CaCl2 was added to a final concentration of 1 mM. Trypsin 
(Promega) was added to obtain a protein:trypsin ratio of 1:50, and a 16 hour incubation at 
37ºC was conducted. The reaction was quenched by adding TFA to obtain a pH<3 in the 
digested solution. 
2.6 Matrix-assisted laser desorption ionization time-off-flight mass spectrometry 
(MALDI-TOF MS) 
The tryptic peptides extracted from the gel slices were concentrated and desalted using 
ZipTipC18 (Millipore, Billerica, MA, USA), and eluted with saturated alpha-cyano-4-hydoxy-
cinnamic acid solution (CHCA) (Sigma) in 50% ACN and 0.1% TFA. One µl sample eluted 
from the matrix was applied to the steel target plate and analysed by MALDI-TOF MS 
(Autoflex & Ultraflex, Bruker Daltonics) and MALDI with tandem mass spectrometry 
(MS/MS) (Ultraflex, Bruker Daltonics). The obtained mass spectra were searched against the 
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M. tuberculosis complex database using MASCOT (http://www.matrixscience.com). The 
search parameters were: 100 ppm tolerance as maximum mass error, monoisotopic mass 
value, and fixed modification of cysteine by carboxymethyl. A protein was regarded 
identified if the matched peptide mass fingerprint covered 20% of the complete protein 
sequence. An assignment with sequence coverage below 20% was only accepted if one or 
more of the main peaks were identified by MALDI MS/MS with a significant MASCOT 
score (above 95% certainty). 
 
2.7 Liquid chromatography (LC) Electrospray Ionisation (ESI) with MS/MS 
On-line LC-MS/MS was performed using the Ultimate high pressure liquid chromatography 
(HPLC) equipment (LC Packings) and an ESI-Q-TOF Ultima Global instrument (Waters, 
Micromass, Manchester, UK). One of two different columns were used, either a capillary 0.3 
x 150 mm C18 reverse phase column (LC Packings) or a nano 0.075 x 150 mm C18 reverse 
phase in-house packed column. The flow rate through the columns was 3 µl/min for the 
capillary column and 0.2 µl/min for the nano column. The solvent gradient went from 5% B 
to 60% B in 42 minutes, then from 60% B to 95% B in 10 minutes, ending with constant 95% 
B for 5 minutes. Solvent A was aqueous 2% ACN in 0.1% TFA, whereas solvent B was 
aqueous 90% ACN in 0.1% TFA. Proteolytic peptide profiles were acquired in data-
dependent MS/MS mode from 3 to 60 minutes with a maximum of 40 seconds spectral 
accumulation time, 10 seconds for each of a maximum of four selected peptides from each 
scan window. The electrospray voltage was set to 3kV and 2.4kV, respectively for the 
capillary and nano setup. The collision energy was set to variable using the charge recognition 
option. The obtained data was searched against the publicly available M. tuberculosis 
complex database using MASCOT Deamon or against the Removed-Signal-Sequence 
database described below. The search results from the different LC-MS/MS analyses were 
stored and combined in a publicly available system (http://genesis.ugent.be/ms_lims/). 
 
2.8 Determination of N-terminal start sites in predicted secreted proteins 
The Neural Network method (SignalPNN) and the Hidden Markov Model (SignalPHMM) for 
predicting signal peptides are publicly available at the SignalP server 
(http://www.cbs.dtu.dk/services/SignalP/). All proteins in the proteome of M. tuberculosis 
H37Rv that were predicted to have a signal peptidase I cleavage site by either of the two 
SignalP methods (v 2.0) were compiled in a MASCOT searchable database after removal of 
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the predicted signal peptide. This database is referred to as the Removed-Signal-Sequence 
database and is available at (http://www.bioinfo.no/publications/wiker2006/) 
 
One-sided binomial test (Clopper-Pearson) was used to investigate if there were any 
correlation between the AXA motif present in position -1 to -3 relative to the experimentally 
identified cleavage sites.  
3 Results 
 
3.1 Identification of M. tuberculosis culture filtrate proteins from Two-dimensional (2D) 
PAGE using MALDI 
 
The major goal of this study was to do a comprehensive proteomic analysis of culture filtrates 
of M. tuberculosis H37Rv with minimal content of intracellular proteins in order to identify as 
many secreted proteins as possible. Three different batches, A, B and C, of 3-4 week old M. 
tuberculosis H37Rv culture filtrates were compared by both SDS-PAGE and 2D-PAGE. The 
batches had highly similar protein profiles, and the major secreted proteins like the antigen 85 
components, MPT32, MPT63, MPT64 and MTC28 were found to constitute a substantial part 
of the total protein in all three batches. In contrast, many proteins thought to be intracellularly 
derived were found to be minor constituents. In particular we did not observe GroEL1 or 
GroEL2 proteins in these culture filtrates which is in accordance with previous observations 
on this type of culture filtrate [33]. A representative 2D-PAGE pattern of the culture filtrate 
from batch A is shown in figure 1 and the corresponding SDS-PAGE profile in figure 2. The 
majority of spots were found in the area between pH 4.0 and 6.5 (Fig. 1). The area between 
pH 6.5 and pH 10.0 did not contain CBB stained spots (results not shown). All the detected 
spots in the CBB-stained 2D-PAGE gels (Fig. 1) were excised and subjected to in-gel 
digestion followed by MALDI-TOF-MS and/or MALDI MS/MS analysis. Three-hundred and 
eighteen spots were identified as 118 unique gene products (Table 1). The identified proteins 
were classified according to the M. tuberculosis H37Rv gene annotation 
(http://sanger.ac.uk/projects/M_tuberculosis/Gene_list/).  
 
3.2 Protein identification by LC-ESI-MS/MS 
The M. tuberculosis H37Rv culture filtrate was also analysed using two different LC-MS/MS 
approaches. Firstly, the unfractionated culture filtrate of batch A was trypsinated in solution, 
and analysed directly with LC-MS/MS. The peptides to be fragmented by MS/MS were 
limited by only selecting peptides within specified molecular mass windows. The windows 
chosen were 300-400 Da, 400-500 Da, 500-600 Da, 600-700 Da, 700-800 Da, 800-900 Da, 
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900-1000 Da, 1000-1300 Da, 1300-2000 Da and 300-2000 Da. Secondly, in order to identify 
more proteins, the culture filtrates of batch A, B and C were prefractionated using SDS-PAGE 
prior to capillary or nano LC-MS/MS analysis. A total of 10 gel slices were cut and in-gel 
digested with trypsin (Fig. 2). In total, 199 distinct gene products were identified from the 
LC-MS/MS analysis based on at least one identified peptide per protein with a MASCOT 
confidence level above 95% (Table 1). Information about the reliability of each identification, 
like number of peptides matching each protein, is given in supplementary Table 1. The 
protein profile of the three batches showed that proteins with predicted signal peptide using 
Signal P constituted a major part of all three: batch A 60%, batch B 69% and batch C 83%. 
 
3.3 Determination of signal peptidase I cleavage sites  
 
Possible cleavage sites for signal peptidase I can be determined by various computational 
methods. The SignalP method for prediction of secreted proteins based on Neural Network 
method (NN) or the Hidden Markov Model (HMM) [34, 35] is one of the most reliable 
programs for this purpose [36]. Of the 257 proteins identified by 2D-PAGE/MALDI-TOF-MS 
and/or 1D-SDS-PAGE/LC-MS/MS, 159 had a predicted signal peptide by SignalP (Table 1 
and supplementary table 2).  
 
To identify the cleavage site for signal peptidase I of secreted proteins of M. tuberculosis 
H37Rv and to verify a cleavable signal peptide, each mass finger print was searched against 
the Removed-Signal-Sequence database using MASCOT. Out of the 159 identified proteins 
with a predicted signal peptide, 41 N-terminal peptides lying immediately C-terminally to a 
predicted cleavage site were identified (Table 2), which confirms the existence of a cleavable 
signal sequence in many of these proteins. The signal peptides of these proteins are shown in 
table 3. 
 
Interestingly, the SignalP method predicted in total 188 cleavage sites in 127 of the proteins 
predicted to be processed by Signal peptidase I and 85 of these cleavage sites had an AXA 
motif at the N-terminal side (Supplementary table 2). However, among the 127 proteins, 35 
out of 41 experimentally verified cleavage sites had an AXA motif (Table 2). The one-sided 
binomial test showed that this observation was highly signficant (p<0.000003). 
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Twenty-five of the identified N-terminal cleavage sites were in agreement with both the 
Neural Network method and the Hidden Markov Model predictions, while 10 corresponded 
only with the cleavage site predicted by the Hidden Markov Model, and 6 only with the 
Neural Network method. Furthermore, 13 of the identified N-terminal sequences started with 
aspartic acid in the (+1) position and proline in the (+2) position (the DP motif), which may 
serve as a sorting or recognition signal following translocation and cleavage by signal 
peptidase I [37]. Interestingly, the N-terminal cleavage site of signal peptidase I predicted by 
SignalP in 5 potential lipoproteins (Rv0526, Rv0999, Rv2911, Rv3668c and Rv3759c) were 
also detected; with the predicted lipobox further N-terminally to the detected cleavage sites. 
This finding opens for the possibility that lipoproteins might be alternatively cleaved and 
processed by signal peptidase I and signal peptidase II.  
 
All the experimental data were searched against the NCBI database, but none of the identified 
peptides corresponded to potential signal peptides. 
 
3.4 Functional distribution of the identified M. tuberculosis H37Rv culture filtrate 
proteins 
The annotated M. tuberculosis H37Rv proteins have been classified into 12 distinct functional 
groups (http://genolist.pasteur.fr/TubercuList/). The 257 proteins identified by 2D-PAGE 
MALDI-TOF-MS and SDS-PAGE combined with LC-MS/MS in this study were distributed 
across ten of those functional groups (Fig. 3). Most of the identified proteins are involved in 
prokaryotic cell wall and cell processes (functional group 3, 40.2%) and intermediary 
metabolism and respiration (functional group 7, 25.0%).  
 
3.5 Isoelectric point and molecular mass distribution of the identified M. tuberculosis 
H37Rv culture filtrate proteins 
The methods used in this study for protein identification were able to cover wide pI and 
molecular mass ranges, from a pI value of 3.64 (possible resuscitation-promoting factor 
RpfA, Rv0867c) for protein identified by both 2D-PAGE MALDI and LC-MS/MS to pI value 
12.60 which belonged to Rv3760 identified by LC-MS/MS. The majority of the proteins 
clustered between pI 4-6.5, which is in agreement with previous 2D-PAGE based studies 
performed on culture filtrate proteins (Fig. 4A) [9].  
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The protein with lowest molecular mass in this study was 9.41 kDa (Putative ESAT-6 like 
protein EsxN, Rv1793), as observed by 2D-PAGE/MALDI-TOF-MS. Probable respiratory 
nitrate reductase, narG (Rv1161) with a molecular mass of 136.92 kDa observed by LC-
MS/MS represented the largest identified secreted protein. The majority of the proteins were 
found in the range between 10 to 50 kDa (Fig. 4B). In many cases, the same protein was 
identified from different 2D-PAGE spots, and in different SDS-PAGE fractions with different 
molecular mass and pI, possibly as a consequence of post-translational modifications or 
proteolytic processing. For example, Rv3587c was detected in three different spots (Fig. 1). 
For 45 secreted proteins the observed average molecular mass was 23.6 kDa by 2D-PAGE 
(Supplementary Table 1). The average theoretical mass of these proteins was 31.0 kDa and 
after removal of the signal peptides as predicted by the NN method, it was 26.5 kDa. With 16 
potential lipoproteins the observed average molecular mass was 29.5 kDa. The theoretical 
masses were 34.4 kDa before and 32.2 kDa after predicted signal peptidase II cleavages. In 57 
proteins without predicted signal peptide the observed average mass was 30.7 kDa while the 
theoretical mass was 32.2 kDa. The differences between average theoretical and average 
observed masses in groups of proteins with and without predicted signal peptides therefore 
supported that signal peptides had been removed from the secreted proteins. 
 
3.6 Novel protein identification 
Among the 257 proteins identified in this study, 92 proteins represent novel identifications. 
Seventy-two of the novel identifications had a N-terminal signal peptide predicted by one or 
both of the Neural Network (NN) and the Hidden Markov Model (HMM) methods, of those, 
13 proteins were predicted to be lipoproteins by ScanProsite (http://au.expasy.org/prosite/). 
Fifty-nine of the novel proteins were without resemblance to other proteins that have been 
functionally characterised previously, showing that there are many proteins with unknown 
functions in the secreted subproteome of M. tuberculosis.  
 
To our knowledge, these results represent the largest number of novel predicted secreted 
proteins in M. tuberculosis culture filtrate reported in one study (Fig. 5), revealing a new part 
of the M. tuberculosis culture filtrate proteome that may prove important for the pathogenesis 
of the bacteria. 
 
3.7 Major M. tuberculosis H37Rv culture filtrate proteins 
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The most abundant proteins in this M. tuberculosis H37Rv culture filtrate as observed by 2D-
PAGE, were the secreted antigen 85 complex (85A (Rv3804c), 85B (Rv1886c), 85C 
(Rv0129c) and 85D (MPT51, Rv3803c)), immunogenic protein MPT63 (Rv1926c), 
immunogenic protein MPT64 (Rv1980c), alanine-, proline-rich secreted protein MPT32, 
Rv1860) and secreted proline-rich protein MTC28 (Rv0040c). In addition, protein members 
of the 6 kDa early secreted antigenic target-6 (ESAT-6) family were also among the abundant 
proteins (Fig. 1). Among the novel proteins identified by 2D-PAGE, Rv0063 (Possible 
oxidoreductase) and Rv3587c (Probable conserved membrane protein) were also relatively 
abundant. Rv3587c has only one predicted transmembrane region which is coincident with its 
predicted signal peptide, indicating that it is a secreted protein rather than a membrane 
protein.  
 
3.8 Identification of ESAT-6 family proteins  
ESAT-6 is the primary component of a family of small proteins without signal peptides 
secreted by an alternative mechanism [37, 38]. The protein members of this family are potent 
T-cell antigens which are essential for the pathogenicity of the bacterium [38]. The culture 
filtrate of M. tuberculosis H37Rv profiled in this study, contained many ESAT-6 proteins: 
EsxG (Rv0287), EsxL (Rv1198), EsxN (Rv1793), EsxO (Rv2346c), EsxB (Rv3874) and 
EsxA (Rv3875). One protein spot analysed in this study (Fig. 1, ¤) matched several ESAT-6 
family member proteins that are highly homologous and difficult to resolve by 2D-PAGE or 
MS due to highly similar masses and isoelectric points. Therefore the mass fingerprint from 
this protein spot matched all these proteins: EsxJ (Rv1038c), EsxK (Rv1197), EsxP 
(Rv2347c) and EsxW (Rv3620c).  We also identifed 3 peptides by LC-MS/MS that could be 
derived from any of these proteins or EsxM (Rv1792). Two peptides identified by LC-
MS/MS matched all of these proteins: EsxI (Rv1037c), EsxL (1198), EsxN (Rv1793), EsxO 
(Rv2346c) and EsxV (Rv3619c). One peptide identified by LC-MS/MS matched both EsxK 
(Rv1197) and EsxP (Rv2347c).  
 
3.9 Identifications of Lipoproteins 
 
Lipoproteins (Lpp) represent a distinct class of proteins, associated with the membrane 
compartment of the bacteria by means of post-translational lipid modifications, and several 
are found to be surface accessible [39, 40]. These proteins are functionally diverse, and can be 
involved in interactions between the organism and the host [41]. We identified 36 potential 
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lipoproteins, predicted to have lipid modification sites by the ScanProsite program. Thirteen 
of these proteins had not been identified previously in M. tuberculosis.  
 
4 Discussion 
 
Proteins secreted by M. tuberculosis are believed to mediate important biological functions by 
interacting with host cells, notably macrophages, and are thus potentially important for 
virulence and pathogenesis [22, 42-45]. Many proteomic studies using culture filtrates from 
M. tuberculosis have been published [9, 10, 16, 29, 46, 47]. However, the number of 
identified proteins predicted to be secreted, as based on the presence of a signal peptide in the 
preprotein, has been relatively low, compared to the total number of proteins identified in 
these studies (Fig.5). This study provides a considerably more comprehensive picture of the 
secreted protein repertoire of M. tuberculosis H37Rv than previously shown. It was achieved 
by analysis of a unique type of culture filtrate with almost neglectible content of 
intracellularly derived proteins, produced by Sadamu Nagai (Osaka, Japan), from cultures of 
M. tuberculosis H37Rv on the wholly synthetic Sauton medium. The first proteomic study of 
M. tuberculosis by Nagai et al. [28], focused on secreted proteins in which 12 culture filtrate 
proteins were chromatographically purified and partially characterized. The presently 
analyzed culture filtrates had similar quality as the previously analysed culture filtrate in 
which the antigen 85 complex constitute a major part of the total protein. Looking further 
back in the literature, similar observations of the composition of culture filtrates of M. 
tuberculosis H37Rv were done by Yoneda and Fukui et. al., 1965 [53] also working in Osaka 
Japan. They found that the α antigen (antigen 85) comprised 40% of the total protein which is 
in line with our present results. These results are different, and much higher than what is 
usually found in M. tuberculosis culture filtrates. The important question is whether the 
phenomenon is due to excellent culture technique or whether this is a strain specific 
phenomenon. It is not possible to determine this at the present stage, but we have previously 
worked with several BCG culture filtrates produced by Nagai in the same way as for M. 
tuberculosis. These culture filtrates had significant levels of intracellular proteins. It is 
therefore possible that the local M. tuberculosis strain of H37Rv used in Osaka, Japan has a 
distinct genetic feature, being resistant to the lysis regularly occurring in M. tuberculosis 
complex organisms. An autolytic toxin, MazF-like toxin gene, has been postulated in M. 
tuberculosis [54], which is proposed to be involved in cell response to starvation and may be 
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the prokaryotic equivalent of apoptosis. Mutations affecting this enzyme could explain the 
nature of Nagai`s culture filtrate.   
 
The N-terminal peptides of mature secreted proteins were identified in 41 of 159 exported 
proteins predicted by SignalP. These results verify the existence of a cleavable signal 
sequence in those proteins, and shows that the SignalP program provides a correct 
identification of the signal peptide and its cleavage site in a large fraction of the predicted 
secreted proteins. However, a majority of the identified N-terminal peptides of mature 
secreted proteins had an AXA motif N-terminally to their cleavage sites, showing that the 
mycobacterial signal peptidase I, preferentially recognizes the AXA motif. This motif is 
underestimated by SignalP, possibly due to the presence of only a few mycobacterial proteins 
in SignalPs training set. This might partly explain the failure to identify the N-terminal 
peptide of the other predicted secreted proteins identified in this study. Our results shows that 
there is a need for a separate algorithm for prediction of secreted proteins in acid-fast bacilli. 
This has not been possible before because few signal peptidase I cleavage sites in 
mycobacteria have been known, but with the data presented in this paper this goal is much 
closer. 
 
Exported lipoproteins have been shown to be exposed at the surface of M. tuberculosis and M. 
bovis. They are however vulnerable to proteolytic cleavage relatively close to the N-terminal 
cysteine and are subsequently released as soluble protein in the culture filtrate. Similar 
observations have also been reported in Bacillus subtilis [55]. The lipoproteins we identified 
in the culture filtrate may represent such proteolytically processed proteins. Our method for 
identification of N-terminal peptides of mature secreted proteins is not applicable to intact 
processed lipoproteins because information about the masses of secondary modification on 
the N-terminal cysteine is not part of the preferences in MASCOT. However, we found five 
potential N-terminal peptides among the 36 predicted lipoproteins. Closer inspection revealed 
that the cleavage site for signal peptidase I, predicted by SignalP and observed in our study, 
lies C-terminally from the predicted cleavage site for signal peptidase II. This finding 
suggests that some lipoproteins may be alternatively processed by signal peptidase I or II, and 
represent a mechanism for dual localization in A) the extracellular environment or B) as  
lipoprotein in the cell wall. 
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In conclusion, we have obtained a comprehensive picture of the M. tuberculosis H37Rv 
culture filtrate protein repertoire. Two-hundred-fifty-seven proteins were identified by a 
combination of 2D-PAGE/MALDI-TOF-MS and LC-MS/MS. Sixty-two percent of them had 
predicted N-terminal signal peptide, suggesting that the culture filtrate was particularly 
enriched with respect to secreted proteins. The 92 novel proteins identified in this study 
provide further insight into the M. tuberculosis secreted proteome, and reveal a large portion 
of previously unidentified proteins with unknown function, which might be involved in the 
pathogenesis of tuberculosis. We have improved the methods for identification of secreted 
proteins by referring mass fingerprints of proteins to a database of secreted proteins with 
predicted signal peptides removed. This method is also useful for determining the cleavage 
site for mycobacterial signal peptidase I, which is shown to preferentially recognize the AXA 
motif.  
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Figure legends 
 
Figure 1. 2D-PAGE of culture filtrate proteins from M. tuberculosis H37Rv. Two mg of 
culture filtrate proteins were applied to 18 cm IPG strips with different pH range in the first 
dimension isoelectric focusing, followed by SDS-PAGE in the second dimension. Proteins 
were visualized by CBB staining. Predicted secreted proteins are indicated by arrows and 
their Rv number. Molecular weight markers are indicated to the left. Note: ¤ indicates protein 
spots identified as different ESAT-6 family member proteins (Rv1038c, Rv1197, Rv1792, 
Rv2347c and Rv3620c). 
 
Figure 2. One-dimensional SDS-PAGE of M. tuberculosis H37Rv culture filtrate proteins. 
The molecular weight standard is shown on the left, and the fraction numbers on the right. 
Explanation of the fraction numbers: (1) >160 kDa, (2) ranges from 105-160 kDa, (3) ranges 
from 75-105 kDa, (4) ) ranges from 50-75 kDa, (5) ranges from 35-50 kDa, (6) ranges from 
30-35 kDa, (7) ranges from 25-30 kDa, (8) ranges from 15-25 kDa, (9) ranges from 15-10 
kDa, (10) <10 kDa. 
 
 
Figure 3. Functional categorization of the identified M. tuberculosis H37Rv culture filtrate 
proteins. Explanation of functional category numbers: (0) virulence, detoxification, and 
adaptation, (1) lipid metabolism, (2) information pathway, (3) cell wall and cell processes, (6) 
PE/PPE family member proteins, (9) regulatory proteins, (10) conserved hypothetical 
proteins, and (16) conserved hypothetical proteins with an orthologue in M. bovis. Functional 
group codes are taken from the web server (http://genolist.pasteur.fr/TubercuList/). 
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Figure 4. pI (A) and molecular weight (B) distribution of the identified M. tuberculosis 
H37Rv culture filtrate proteins. 
 
 
Figure 5. A comparison between the number of identified M. tuberculosis culture filtrate 
proteins and the total number of protein identifications in selected previous studies. a) The 
total number of proteins with predicted N-terminal signal peptide in M. tuberculosis genome 
predicted by Hidden Markov Model (HMM) method, b) Culture filtrate protein identified by 
Rosenkrands, I. (2000) [9], c) Culture filtrate proteins identified by Mattow, J. (2003) [16], d) 
culture filtrate proteins identified in this study. The black part of the figure represents number 
of proteins with predicted signal peptide, while the white part represents proteins without 
predicted signal peptide.
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Table 1: List of M. tuberculosis H37Rv culture filtrate proteins identified by 2D-PAGE combined with MALDI-TOF MS and liquid 
chromatography coupled MS/MS.  
 
Gene 
number    
Gene 
name 
Identification  
method 
Functional 
groupb 
Signal 
peptide 
prediction 
by NNc 
Signal 
peptide 
prediction 
by HMMd
Protein identity References 
Rv0170 mce1B LC-MS/MS 0 0.75 0.65 Mce family protein e 
Rv0172 mce1D LC-MS/MS 0 0.66 0.98 Mce family protein f 
Rv0174 mce1F LC-MS/MS 0 0.95 0.88 Mce family protein g 
Rv0350 dnaK MS&LC-MS/MS 0 0.14 0.01 70 kDa heat shock protein h,i,j,k,l 
Rv0563 htpY LC-MS/MS 0 0.879 0.973 Probable transmembrane heat shock protease  f 
Rv1477 - LC-MS/MS 0 0.9 1 Hypothetical invasion protein   
Rv1908c katG MS&LC-MS/MS 0 0.1 0 Catalase peroxidase peroxynitritase T  k,m 
Rv1932 tpx MS 0 0.18 0.01 Probable thiol peroxidase h,i,j,l 
Rv2006 otsB1 LC-MS/MS 0 0.19 0 Probable trehalose-6-phosphate phosphatase  g 
Rv2190c - LC-MS/MS 0 0.74 1 Conserved hypothetical protein   
Rv2299 htpG LC-MS/MS 0 0.09 0 Probable chaperone protein g 
Rv3418c - LC-MS/MS 0 0 0 10 kDa Chaperonin h,i,j 
Rv3759c proX LC-MS/MS 0 0.92 1 Possible osmoprotectant binding lipoprotein e 
Rv3846 sodA LC-MS/MS 0 0.05 0 Superoxide dismutase i,m 
Rv0129c fbpC MS&LC-MS/MS 1 0.67 1 Secreted antigen 85C j,k,m 
Rv0242c fabG4 LC-MS/MS 1 0.18 0 Probable 3-oxoacyl reductase (acyl-carrier protein) i 
Rv0244c fadE5 MS 1 0.16 0 Probable acyl-CoA dehydrogenase e 
Rv0436c   pssA LC-MS/MS 1 0.66 0.99 Probable CDP-Diacylglycerol-serine O-phosphatidyltransferase  
Rv1074c fadA3 MS 1 0.42 0 Probable β-ketoacetyl CoA thiolase h,i,n 
Rv1323 fadA4 MS 1 0.25 0 Probable acetyl-CoA acetyltransferase j 
Rv1886c fbpB MS&LC-MS/MS 1 0.81 1 Secreted antigen 85B  h,j,k,l,m 
Rv2831 echA16 MS&LC-MS/MS 1 0.24 0 Probable enoyl-CoA hydratase h 
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Rv3803c fbpD MS&LC-MS/MS 1 0.93 1 Secreted antigen MPT51 h,j,k,l,m 
Rv3804c fbpA MS&LC-MS/MS 1 0.68 1 Secreted antigen 85A (Myocolyl transferase)  h,j,k,l,m 
Rv0002 dnaN MS 2 0.25 0 DNA polymerase III (β-chain, DNA nucleotidyltransferase)  
Rv0009 ppiA MS 2 0.19 0 Possible iron-regulated peptidyl-prolyl cis-trans isomerase h,j,k,l,m 
Rv0054 ssb MS 2 0.19 0 Possible single-strand binding protein j 
Rv0631c recC LC-MS/MS 2 0.15 0 Probable exonuclease V g 
Rv3201c - LC-MS/MS 2 0.46 0.84 Possible ATP-dependant DNA helicase  g 
Rv0012 - LC-MS/MS 3 0.5 0.67 Probable conserved membrane protein  g 
Rv0040c mtc28 MS&LC-MS/MS 3 0.66 1 Secreted proline-rich protein o 
Rv0064 - LC-MS/MS 3 0.68 0.64 Probable conserved transmembrane protein g 
Rv0116c - LC-MS/MS 3 0.79 1 Possible conserved membrane protein  
Rv0173 mce1E LC-MS/MS 3 0.81 0.996 Possible Mce-family lipoprotein f 
Rv0203 - LC-MS/MS 3 0.86 1 Possible exported protein   
Rv0219 - LC-MS/MS 3 0.505 0.625 Probable conserved transmembrane protein  
Rv0237 lpqI MS 3 0.84 1 Probable conserved lipoprotein f 
Rv0265c fecB2  LC-MS/MS 3 0.526 0.996 Probable periplasmic iron-transport lipoprotein e 
Rv0283 - LC-MS/MS 3 0.252 0 Possible conserved membrane protein  f,g 
Rv0287 esxG MS/MS&LC-MS/MS 3 0.32 0.01 ESAT-6 like protein  h 
Rv0309 - LC-MS/MS 3 0.89 1 Possible conserved exported protein   
Rv0398c - MS&LC-MS/MS 3 0.83 1 Possible secreted protein  
Rv0402c mmpL1 LC-MS/MS 3 0.8 0.9 Probable conserved transmembrane transport protein g 
Rv0411c glnH MS&LC-MS/MS 3 0.71 1 Probable glutamine-binding lipoprotein  
Rv0446c - LC-MS/MS 3 0.7 0.81 Possible conserved transmembrane protein   
Rv0477 - MS/MS&LC-MS/MS 3 0.9 1 Possible conserved secreted protein   
Rv0506 mmpS2 LC-MS/MS 3 0.873 0.879 Probable conserved membrane protein   
Rv0559c - LC-MS/MS 3 0.83 1 Possible conserved secreted protein   
Rv0583c lpqN LC-MS/MS 3 0.64 1 Probable conserved lipoprotein e 
Rv0677c mmpS5 MS&LC-MS/MS 3 0.84 0.99 Possible conserved membrane protein  
Rv0680c - MS/MS 3 0.82 1 Probable conserved transmembrane protein  
Rv0732 secY LC-MS/MS 3 0.69 0.82 Probable preprotein translocase  
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Rv0774c - LC-MS/MS 3 0.488 0.999 Probable conserved exported protein   
Rv0835 lpqQ MS&LC-MS/MS 3 0.86 1 Possible lipoprotein  
Rv0838 lpqR MS&LC-MS/MS 3 0.86 1 Probable conserved lipoprotein  
Rv0867c rpfA LC-MS/MS 3 0.67 1 Possible resuscitation-promoting factor  
Rv0876c - LC-MS/MS 3 0.24 0 Possible conserved transmembrane protein  g 
Rv0928 pstS3 MS&LC-MS/MS 3 0.79 1 Periplasmic phosphate-binding lipoprotein n 
Rv0932c pstS2 MS&LC-MS/MS 3 0.91 1 Periplasmic phosphate-binding lipoprotein e 
Rv0934 pstS1 MS&LC-MS/MS 3 0.93 1 Periplasmic phosphate-binding lipoprotein h,k,l 
Rv0996 - LC-MS/MS 3 0.67 0.99 Probable conserved transmembrane protein   
Rv1037 esxI MS/MSLC-MS/MS 3 0.13 0 Putative ESAT-6 like proteins: EsxI (Rv1037c), EsxL (Rv1198), h 
 group     EsxO (Rv2346c) and EsxV (Rv3619c)  
Rv1038c esxJ group MS&LC-MS/MS 3 0.13 0 Putative ESAT-6 like proteins: EsxJ (Rv1038c), EsxK (Rv1197),   
i 
      EsxP (Rv2347c) and EsxW (Rv3620c)  
Rv1075c - LC-MS/MS 3 0.77 1 Conserved exported protein g 
Rv1166 LpqW LC-MS/MS 3 0.91 1 Probable conserved lipoprotein  
Rv1174c TB8.4 LC-MS/MS 3 0.8 1 Low molecular weight T-cell antigen p 
Rv1183 mmpL10 LC-MS/MS 3 0.69 0.97 Probable conserved transmembarne transport protein g 
Rv1197 esxK LC-MS/MS 3 0.11 0 Putative ESAT-6 like protein h 
Rv1198 esxL MS/MS&LC-MS/MS 3 0.11 0 Putative ESAT-6 like protein h 
Rv1252c lprE LC-MS/MS 3 0.617 0.932 Probable lipoprotein  
Rv1269c - MS 3 0.7 1 Probable conserved secreted protein e,n 
Rv1270c lprA LC-MS/MS 3 0.75 1 Possible lipoprotein f,g 
Rv1371 - MS 3 0.1 0 Probable conserved membrane protein  g 
Rv1382 - LC-MS/MS 3 0.7 0.77 Probable export or membrane protein  
Rv1435c - LC-MS/MS 3 0.73 1 Probable conserved proline-, glycine-, valine-rich secreted protein  
Rv1488 - LC-MS/MS 3 0.758 0.999 Possible conserved exported protein e 
Rv1541c LprI LC-MS/MS 3 0.79 1 Possible lipoprotein   
Rv1793 esxN MS/MS&LC-MS/MS 3 0.1 0 Putative ESAT-6 like protein  n 
Rv1845c - LC-MS/MS 3 0.905 0.994 Conserved hypothetical transmembrane protein g 
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Rv1860 apa MS/MS&LC-MS/MS 3 0.82 1 Alanine-, proline-rich secreted protein h,j,k,l,m 
Rv1884c rpfC LC-MS/MS 3 0.56 0.12 Possible resucitation-promoting factor  
Rv1899c lppD LC-MS/MS 3 0.679 0.989 Possible lipoprotein e 
Rv1910c - LC-MS/MS 3 0.89 1 Possible exported protein   
Rv1911c lppC LC-MS/MS 3 0.61 1 Probable lipoprotein  
Rv1926c mpt63 MS&LC-MS/MS 3 0.92 1 Immunogenic protein MPT63 g,h,i,m 
Rv1980c mpt64 MS&LC-MS/MS 3 0.93 1 Immunogenic protein MPT64 h,i,j,k,l,m 
Rv1984c cfp21 LC-MS/MS 3 0.86 1 Probable cutinase h,i,l 
Rv2060 - LC-MS/MS 3 0.7 0.98 Possible conserved integral membrane protein g 
Rv2080 lppJ MS/MS 3 0.78 1 Possible lipoprotein  
Rv2224c - LC-MS/MS 3 0.74 1 Possible exported protease f,g 
Rv2253 - MS&LC-MS/MS 3 0.94 1 Possible unknown secreted protein  
Rv2301 cut2 MS/MS&LC-MS/MS 3 0.83 1 Possible cutinase i,l 
Rv2346c esxO MS/MS&LC-MS/MS 3 0.09 0 Putative ESAT-6 like protein  g 
Rv2376c cfp2 MS/MS&LC-MS/MS 3 0.95 1 Low-molecular-weight antigen  i 
Rv2450c rpfE LC-MS/MS 3 0.77 1 Possible resucitation-promoting factor  
Rv2544 lppB LC-MS/MS 3 0.577 0.603 Probable conserved lipoprotein   
Rv2563 - LC-MS/MS 3 0.662 0.954 Probable glutamine-transport transmembrane protein f 
Rv2575 - LC-MS/MS 3 0.28 0.01 Possible conserved glycine-rich membrane protein  m 
Rv2576c - LC-MS/MS 3 0.58 0.94 Possible conserved membrane protein   
Rv2585c - LC-MS/MS 3 0.883 1 Possible conserved lipoprotein g 
Rv2668 - MS&LC-MS/MS 3 0.87 1 Possible exported alanine-, valine-rich protein  
Rv2693c - LC-MS/MS 3 0.65 0.95 Probable conserved alanine-, leucine-rich integral membrane protein 
 
Rv2721c - MS&LC-MS/MS 3 0.76 1 Possible alanine-, glycine-rich integral transmembrane protein  e 
Rv2799 - MS&LC-MS/MS 3 0.62 0.89 Probable membrane protein  
Rv2873 mpt83 MS/MS&LC-MS/MS 3 0.89 1 Immunogenic cell surface lipoprotein, MPT83  q 
Rv2875 mpt70 MS/MS&LC-MS/MS 3 0.88 1 Major secreted immunogenic protein MPT70 r 
Rv2878c mpt53 MS&LC-MS/MS 3 0.69 1 Soluble secreted antigen MPT53 h,i,j,k,l,m 
Rv2905 lppW LC-MS/MS 3 0.89 1 Probable conserved alanine-rich lipoprotein   
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Rv2911 dacB2 MS&LC-MS/MS 3 0.94 1 Probable D-alanyl, D-alanine carboxypeptidase  
Rv2945c lppX MS 3 0.75 1 Probable conserved lipoprotein e 
Rv2994 - LC-MS/MS 3 0.6 0.53 Probable conserved integral membrane protein  
Rv3004 cfp6 LC-MS/MS 3 0.75 1 Low-molecular-weight protein antigen  
Rv3006 lppZ MS&LC-MS/MS 3 0.87 1 Probable conserved lipoprotein  e 
Rv3016 lpqA MS/MS 3 0.78 1 Probable lipoprotein  
Rv3036c TB22.2 LC-MS/MS 3 0.84 1 Probable conserved secreted protein h,i,j,k 
Rv3044 fecB MS&LC-MS/MS 3 0.65 1 Probable FeIII-dicitrate-binding periplasmic lipoprotein  s 
Rv3193c - LC-MS/MS 3 0.83 1 Probable conserved transmembrane protein f 
Rv3194c - LC-MS/MS 3 0.932 1 Possible conserved secreted protein f 
Rv3240c secA1 LC-MS/MS 3 0.229 0 Probable preprotein translocase subunit f 
Rv3244c lpqB MS&LC-MS/MS 3 0.85 1 Probable conserved lipoprotein g 
Rv3402c - LC-MS/MS 3 0.36 0.97 Conserved hypothetical protein  
Rv3495c lprN LC-MS/MS 3 0.77 1 Possible Mce-family lipoprotein g 
Rv3584 lpqE LC-MS/MS 3 0.88 1 Possible conserved lipoprotein  e 
Rv3587c - MS&LC-MS/MS 3 0.52 0.98 Probable conserved membrane protein  
Rv3629c - LC-MS/MS 3 0.72 0.99 Probable conserved integral membrane protein   
Rv3682 ponA2 MS&LC-MS/MS 3 0.76 1 Probable bifunctional membrane-associated penicillin-binding protein 
e 
Rv3693 - LC-MS/MS 3 0.842 0.997 Possible conserved membrane protein f 
Rv3760 - LC-MS/MS 3 0.608 0.924 Possible conserved membrane protein  
Rv3835 - MS 3 0.45 0 Probable conserved membrane protein g 
Rv3874 esxB MS&LC-MS/MS 3 0.15 0 10 kDa culture filtrate antigen (CFP10) h,i,j 
Rv3875 esxA MS/MS&LC-MS/MS 3 0.13 0 6 kDa early secretory antigenic target (ESAT-6) h,i 
Rv3917c parB LC-MS/MS 3 0.573 0.991 Probable chromosome partitioning protein e 
Rv3428c - LC-MS/MS 5 0.121 0 Possible transposase  f 
Rv0285 PE5 LC-MS/MS 6 0.58 0.99 PE family protein   
Rv0453 PPE11 LC-MS/MS 6 0.326 0.833 PPE family protein  g 
Rv1386 PE15 LC-MS/MS 6 0.61 0.98 PE family protein   
Rv1759c wag22 LC-MS/MS 6 0.44 0.87 PE-PGRS family protein   
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Rv2430c PPE41 MS/MS&LC-MS/MS 6 0.2 0 PPE family protein   
Rv2431c PE25 MS&LC-MS/MS 6 0.17 0 PE family protein  
Rv3872 PE35 LC-MS/MS 6 0.26 0.03 PE family-related protein  
Rv0062 celA MS 7 0.6 0.18 Possible cellulase (Endoglucanase)  
Rv0063 - MS&LC-MS/MS 7 0.65 1 Possible oxidoreductase  
Rv0066 icd2 LC-MS/MS 7 0.263 0.007 Probable isocitrate dehydrogenase  e,g 
Rv0075 - LC-MS/MS 7 0.091 0 Probable aminotransferase  e 
Rv0125 pepA MS/MS&LC-MS/MS 7 0.93 1 Probable serine protease  t 
Rv0211 pckA LC-MS/MS 7 0.094 0 Probable iron-regulated phosphoenol pyruvate carboxykinase f,g 
Rv0291 mycP3 MS&LC-MS/MS 7 0.73 1 Probable membrane-anchored mycosin  e 
Rv0315 - MS&LC-MS/MS 7 0.71 1 Possible β-1,3-glucanase precursor n 
Rv0363c fba MS 7 0.16 0 Probable fructose-bisphosphate aldolase h,j 
Rv0408 pta LC-MS/MS 7 0.43 0 Probable phosphate acetyltransferase  
Rv0462 lpd MS&LC-MS/MS 7 0.21 0.03 Dihydrolipoamide dehydrogenase g 
Rv0501 galE2 MS 7 0.28 0 Possible UDP-glucose 4-epimerase g 
Rv0526 - MS&LC-MS/MS 7 0.87 1 Possible thioredoxin protein  e 
Rv0843 - LC-MS/MS 7 0.1 0 Probable dehydrogenase  
Rv0851c - LC-MS/MS 7 0.168 0.573 Probable short-chain-type dehydrogenase/reductase  
Rv0884c serC MS 7 0.16 0 Possible phosphoserine aminotransferase  h,i 
Rv1050 - LC-MS/MS 7 0.28 0.97 Probable oxidoreductase  g 
Rv1077 cbs MS 7 0.18 0.04 Probable cystathionine β-synthase  h,j,n 
Rv1098c fum LC-MS/MS 7 0.15 0 Probable fumarase f,g 
Rv1161 narG LC-MS/MS 7 0.08 0 Probable respiratory nitrate reductase f,g 
Rv1310 atpD LC-MS/MS 7 0 0 Possible ATP-synthase, β-chain f,g 
Rv1415 ribA2 MS 7 0.1 0 Probable riboflavin biosynthesis protein   
Rv1436 gap MS 7 0.16 0 Probable glyceraldehyde 3-phosphate dehydrogenase  j 
Rv1437 pgk MS 7 0.16 0 Probable phosphoglycerate kinase e 
Rv1438 tpi MS 7 0.21 0 Probable triosephosphate isomerase j 
Rv1448c tal MS&LC-MS/MS 7 0.22 0.08 Probable transaldolase g 
Rv1449c tkt LC-MS/MS 7 0.15 0 Probable transketolase g 
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Rv1454c qor MS 7 0.07 0 Probable quinone reductase h,j 
Rv1475c acn MS&LC-MS/MS 7 0.37 0 Probable iron-regulated aconitate hydratase h,j 
Rv1812c - LC-MS/MS 7 0.6 0.56 Possible dehydrogenase  m 
Rv1833c - LC-MS/MS 7 0.09 0 Possible haloalkane dehalogenase e 
Rv1837c glcB MS 7 0.23 0 Probable malate synthase  j,n 
Rv1869c - LC-MS/MS 7 0.506 0.538 Probable reductase g 
Rv1876 bfrA MS 7 0.11 0 Probable bacterioferritin n 
Rv2068c blaC MS&LC-MS/MS 7 0.66 1 Class A β-lactamase n 
Rv2110c prcB MS 7 0.2 0 Proteasome (beta subunit) h,i 
Rv2192c TrpD LC-MS/MS 7 0.22 0.08 Probable anthranilate phosphoribosyltransferase                               e 
Rv2200c ctaC LC-MS/MS 7 0.526 0.843 Probable transmembrane cytochrome C oxidase f 
Rv2201 asnB LC-MS/MS 7 0.606 0.995 Probable asparagine synthetase  f 
Rv2220 glnA1 MS&LC-MS/MS 7 0.1 0 Glutamine synthetase  h,i,k 
Rv2236c cobD MS 7 0.39 0.12 Probable cobalamin biosynthesis transmembrane protein g 
Rv2241 aceE LC-MS/MS 7 0.161 0 Probable pyruvate dehydrogenase, E1 component f 
Rv2251 - LC-MS/MS 7 0.492 0.767 Possible flavoprotein g 
Rv2334 cysK1 MS 7 0.21 0 Probable cysteine synthase A  e 
Rv2445c ndkA MS 7 0.21 0 Probable nucleoside diphosphate kinase  i,j 
Rv2465c - MS 7 0.14 0 Probable isomerase  h 
Rv2672 - MS&LC-MS/MS 7 0.84 1 Possible secreted protease f 
Rv2766c fabG5  LC-MS/MS 7 0.463 0.784 Probable short-chain type dehydrogenase/reductase e 
Rv2848c cobB LC-MS/MS 7 0.573 0.618 Probable cobyrinic acid A,C-diamine synthase g 
Rv2874 dipZ LC-MS/MS 7 0.57 0.96 Possible integral membrane C-type cytochrome biogenesis protein 
g 
Rv3106 fprA LC-MS/MS 7 0.52 0.997 NADPH adrenodoxin oxidoreductase   
Rv3111 moaC1 MS 7 0.26 0 Probable molybdenum cofactor biosynthesis protein  
Rv3158 nuoN LC-MS/MS 7 0.522 0.563 Probable NADH dehydrogenase I  f 
Rv3248c sahH LC-MS/MS 7 0.16 0 Probable adenosyl-homocysteinase g 
Rv3310 - MS/MS&LC-MS/MS 7 0.79 1 Possible acid phosphatase V n 
Rv3356c folD MS 7 0.15 0 Probable bifunctional protein: methylene-tetrahydrofolate h,i 
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dehydrogenase/cyclohydrolase 
Rv3397c phyA LC-MS/MS 7 0.178 0 Probable phytoene synthase   
Rv3485c - LC-MS/MS 7 0.51 0.042 Probable short-chain type dehydrogenase/reductase e,h 
Rv3509c ilvX MS 7 0.22 0 Probable acetohydroxyacid synthase j 
Rv3668c - LC-MS/MS 7 0.87 1 Possible protease   
Rv3671c - MS 7 0.65 0.49 Possible membrane associated serine protease  f 
Rv3710 leuA LC-MS/MS 7 0.11 0 2-isopropylmalate synthase h,i 
Rv3725 - LC-MS/MS 7 0.34 0.97 Possible oxidoreductase  
Rv3841 bfrB MS/MS 7 0.08 0 Possible bacterioferritin  e 
Rv3914 trxC MS&LC-MS/MS 7 0.14 0 Thioredoxin (MPT46) h,i,j,k,m 
Rv0015c pknA MS 9 0.47 0.03 Transmembrane serine-, threonine-protein kinase A g 
Rv0472c - LC-MS/MS 9 0.129 0 Probable transcriptional regulatory protein    
Rv0490 senX3 LC-MS/MS 9 0.881 0.999 Putative two component sensor histidine kinase   
Rv0982 mprB LC-MS/MS 9 0.913 0.964 Probable two component sensor kinase  g 
Rv0019c - LC-MS/MS 10 0 0 Conserved hypothetical protein g 
Rv0140 - LC-MS/MS 10 0.122 0 Conserved hypothetical protein   
Rv0164 TB18.5 MS/MS 10 0.47 0 Conserved hypothetical protein h,i,j 
Rv0192 - LC-MS/MS 10 0.17 0 Conserved hypothetical protein n 
Rv0340 - LC-MS/MS 10 0.18 0.01 Conserved hypothetical protein  
Rv0455c - MS&LC-MS/MS 10 0.9 1 Conserved hypothetical protein   
Rv0674 - LC-MS/MS 10 0.88 0.94 Conserved hypothetical protein  
Rv1158c - LC-MS/MS 10 0.82 0.97 Conserved hypothetical alanine-, proline-rich protein   
Rv1186c - LC-MS/MS 10 0.429 0.12 Conserved hypothetical protein g 
Rv1352 - MS/MS&LC-MS/MS 10 0.83 1 Conserved hypothetical protein  
Rv1498A - LC-MS/MS 10 0.112 0.002 Conserved hypothetical protein t 
Rv1729  LC-MS/MS 10 0.25 0.02 Conserved hypothetical protein g 
Rv1784  LC-MS/MS 10 0.147 0 Conserved hypothetical protein  
Rv1804c - MS 10 0.5 1 Conserved hypothetical protein   
Rv1810 - LC-MS/MS 10 0.78 1 Conserved hypothetical protein   
Rv1815 - MS/MS&LC-MS/MS 10 0.87 1 Conserved hypothetical protein  k 
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Rv1827 cfp17 MS 10 0.09 0 Conserved hypothetical protein h,i,l 
Rv1891 - LC-MS/MS 10 0.4 1 Conserved hypothetical protein  
Rv1906c - LC-MS/MS 10 0.78 1 Conserved hypothetical protein   
Rv2074 - MS 10 0.19 0 Conserved hypothetical protein  
Rv2140c TB18.6 MS&LC-MS/MS 10 0.34 0.11 Conserved hypothetical protein  h,i,j 
Rv2314c - MS 10 0.15 0 Conserved hypothetical protein  e 
Rv2469c - LC-MS/MS 10 0.573 0.95 Conserved hypothetical protein   
Rv2631 - MS 10 0.4 0.05 Conserved hypothetical protein  
Rv2823c - LC-MS/MS 10 0.147 0.001 Conserved hypothetical protein g 
Rv3031 - LC-MS/MS 10 0.31 0 Conserved hypothetical protein g 
Rv3267 - MS&LC-MS/MS 10 0.87 1 Conserved hypothetical protein  g 
Rv3354 - LC-MS/MS 10 0.88 1 Conserved hypothetical protein   
Rv3369 - LC-MS/MS 10 0 0 Conserved hypothetical protein u 
Rv3484 cpsA MS 10 0.67 1 Possible conserved protein g 
Rv3627c - LC-MS/MS 10 0.87 1 Conserved hypothetical protein  f 
Rv3705c - LC-MS/MS 10 0.83 1 Conserved hypothetical protein   
Rv3722c - MS&LC-MS/MS 10 0.22 0 Conserved hypothetical protein n 
Rv3881c - MS&LC-MS/MS 10 0.11 0 Conserved hypothetical alanine-, glycine-rich protein m 
Rv3899c - LC-MS/MS 10 0.277 0.748 Conserved hypothetical protein  
Rv0787 - MS&LC-MS/MS 16 0.68 0 Hypothetical protein e 
Rv0999 - LC-MS/MS 16 0.62 0.8 Hypothetical protein  e 
Rv1419 - LC-MS/MS 16 0.5 1 Hypothetical protein  
Rv1887 - LC-MS/MS 16 0.18 0.07 Hypothetical protein  
Rv2401 - MS 16 0.34 0 Hypothetical protein  
Rv3033 - LC-MS/MS 16 0.679 1 Hypothetical protein  n 
Rv3413c - LC-MS/MS 16 0.07 0 Hypothetical alanine-, proline-rich protein   
Rv3491 - MS/MS&LC-MS/MS 16 0.63 1 Hypothetical protein   
Rv3572 - MS&LC-MS/MS 16 0.84 1 Hypothetical protein  
Rv3849 - MS 16 (0.78) 0 Conserved hypothetical protein  j 
MT0066.1a - MS/MS  0.577 1 Hypothetical protein  
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MT2420 - MS/MS  0.109 0 Hypothetical protein  
MT3437.1 - MS  0.097 0 Hypothetical protein  
 
aProteins not annotated in M. tuberculosis H37Rv strain. 
bExplanation of functional group: (0) virulence, detoxification, and adaptation, (1) lipid metabolism, (2) information pathway, (3) cell wall and 
cell processes, (6) PE/PPE family member proteins, (9) regulatory proteins, (10) conserved hypothetical proteins, and (16) conserved 
hypothetical proteins with an orthologue in M. bovis. 
cProbability to have N-terminal signal peptide predicted by Neural Network (NN).  
dProbability to have N-terminal signal peptide predicted by Hidden Markov Model (HMM). 
These proteins have been observed by others previously: e[8], f[5], g[6], h[9], i[10], j[15], k[29], l[31], m[28], n[7], o[48], p[51], q[49], r[50], s[52], 
t[16], u[47] 
 
Rv3849: The signal peptide prediction by the NN method predicts a very short signal peptide, only 6 amino acids, which is unlikely. 
MT0066.1: The nucleotide seqence of MT0066.1 is identical in M. tuberculosis H37Rv and found in positions 65012..65392 on the minus (-) 
strand overlapping with Rv0061 which is annotated as a conserved hypothetical protein (questionable ORF).  7. 
MT2420: The sequence of the peptide identified to belong to MT2420 is not encoded in the M. tuberculosis H37Rv genome. The peptide is 
highly homologous to a peptide found in Rv1793, the only difference being an A in MT2420 instead of an S. The peptide may therefore be 
derived from Rv1793 being modified posttranslationally by removal of a hydroxyl group to change S to A. 
MT3437.1: The nucleotide seqence of MT3437.1 is identical in M. tuberculosis H37Rv and found in positions 3720757..3721236 on the pluss 
(+) strand overlapping slightly with Rv3333c (position 3720782), extending in the gap between this gene and Rv3334 which starts at position 
372125 
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Table 2: Proteins with experimentally identified N-terminal peptide C-terminally to the SignalP predicted N-terminal signal sequence. 
 
Gene 
number 
Gene  
name  
-1 to -3 
position 
N-terminal sequence of mature protein Identification  
method  
Signal peptide 
prediction method 
Rv0040c mtc28 ASA ↓DPLLPPPPIPAPVSAPATVPPVQNLTALPGGSSNR MS  NNa 
Rv0063 - ATA ↓DPAASGWEALSSALGGK LC-MS/MS NNHMMb 
Rv0125 pepA AQA ↓APPALSQDR LC-MS/MS NNHMM 
Rv0129c fbpC AGA ↓FSRPGLPVEYLQVPSASMGR MS & LC-MS/MS NNHMM 
Rv0285 PE5 ASA ↓APVITAVVPPAADPVSLQTAAGFSAQGVEHAVVTAEGVEELGR LC-MS/MS NNHMM 
Rv0291 mycP3 AWA ↓IGPPVVDAAAQPPSGDPGPVAPMEQR MS NN 
Rv0398c - AGA ↓EPTGALPPMTSSGSGPVIGDGDAALR MS  NNHMM 
Rv0455c - AAA ↓DSTEDFPIPR MS & LC-MS/MS NNHMM 
Rv0477 - AQA ↓DPEADPGAGEANYGGPPSSPR LC-MS/MS NNHMM 
Rv0526 - AVA ↓QGGTFEFVSPGGK MS HMMc 
Rv0559c - AQA ↓DDYDAPFNNTIHR LC-MS/MS NNHMM 
Rv0867c rpfA ATA ↓ATDGEWDQVAR LC-MS/MS HMM 
Rv0999 - ASS ↓TTASTGDIAK LC-MS/MS NN 
Rv1158c - AHA ↓DPAPAPAPAPNIPQQLISSAANAPQILQNLATALGATPPLSAPK LC-MS/MS NN 
Rv1174c TB8.4 ASA ↓DPVDAVINTTCNYGQVVAALNATDPGAAAQFNASPVAQSYLR LC-MS/MS NNHMM 
Rv1269c - ANA ↓ADVYGAIAYSGNGSWGR MS NNHMM 
Rv1352 - ARA ↓ETGEQFPGDGVFLVGTDIAPGTYR LC-MS/MS NNHMM 
Rv1477 - ATA ↓DPQTDTIAALIADVAK LC-MS/MS NNHMM 
Rv1804c - AHA ↓GPSGDDAVFLASLER MS NNHMM 
Rv1810 - GKA ↓DPTGDDAAFLAALDQAGITYADPGHAITAAK LC-MS/MS NNHMM 
Rv1815 - ASA ↓DPVLVFPGMEIR LC-MS/MS NNHMM 
Rv1845c - LLA ↓RATWPLR LC-MS/MS HMM 
Rv1886c fbpB AGA ↓FSRPGLPVEYLQVPSPSMGR MS NNHMM 
Rv1906c - AGA ↓DPEPAPTPK LC-MS/MS NNHMM 
Rv1910c - RKA ↓APLAPKAAALGRSMPETPTGDVLTISSPAFADGAP LC-MS/MS HMM 
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Rv1926c mpt63 ALA ↓AYPITGK MS  NNHMM 
Rv1984c cfp21 AHA ↓DPCSDIAVVFAR LC-MS/MS HMM 
Rv2190 - VLA ↓DPADDALAK LC-MS/MS NNHMM 
Rv2253 - AVA ↓AAEPSWNGQYLVTLSANAK MS NN 
Rv2301 cut2 ATA ↓ACPDAEVVFAR LC-MS/MS NN 
Rv2576c - ARA ↓DPVGHQVTYTVTTTSDLMANIR LC-MS/MS NNHMM 
Rv2668 - AWA ↓GDAPIGHIGDTLR MS & LC-MS/MS  HMM 
Rv2693 - SSA ↓AGLLPAIGFALSMAGLILLWRLLR LC-MS/MS HMM 
Rv2911 dacB2 AWA ↓DADVQPAGSVPIPDGPAQTWIVADLDSGQVLAGR MS HMM 
Rv3354 - AQA ↓NPVDDAFIAALNNAGVNYGDPVDAK LC-MS/MS NNHMM 
Rv3491 - ARA ↓LGPPPDGSYSFNQAGVSGVTWTITALCDQPSGTR MS/MS NNHMM 
Rv3668c - AAA ↓DDKLPLGGGAGIVVNGDTMCTLTTIGHDK LC-MS/MS NNHMM 
Rv3705c - ADA ↓HPSEPGVVSYAVLGK LC-MS/MS NNHMM 
Rv3759c proX ANA ↓DPLGSATGSVK LC-MS/MS NNHMM 
Rv3803c fbpD AKA ↓APYENLMVPSPSMGR MS & LC-MS/MS  HMM 
Rv3804c fbpA AGA ↓FSRPGLPVEYLQVPSPSMGR MS HMM 
 
↓ The experimentally identified signal peptidase I cleavage site. 
aN-terminal signal peptide predicted only by Neural Network method (NN). 
bN-terminal signal peptide predicted by both Neural Network method and Hidden Markov Model (NNHMM). 
cN-terminal signal peptide predicted only by Hidden Markov Model (HMM). 
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Table 3: Signal peptides of M. tuberculosis H37Rv culture filtrate proteins with experimentally determined N-terminal mature peptides 
 
Gene 
number 
Signal sequence 
 
Mature 
sequence 
Rv0040c aMIQIARTWRVFAGGMATGFIGVVLVTAGKASA b↓DPL 
Rv0063 MAREISRQTFLRGAAGALAAGAVFGSVRATA ↓DPA 
Rv0125 MSNSRRRSLRWSWLLSVLAAVGLGLATAPAQA ↓APP 
Rv0129c MTFFEQVRRLRSAATTLPRRLAIAAMGAVLVYGLVGTFGGPATAGA ↓FSR 
Rv0285 MTLRVVPEGLAAASAAVEALTARLAAAHASA ↓APV 
Rv0291 MIRAAFACLAATVVVAGWWTPPAWA ↓IGP 
Rv0398c MGVIARVVGVAACGLSLAVLAAAPTAGA ↓EPT 
Rv0455c MSRLSSILRAGAAFLVLGIAAATFPQSAAA ↓DST 
Rv0477 MKALVAVSAVAVVALLGVSSAQA ↓DPE 
Rv0526 MQSRATRRSGALTMRRLVIAAAVSALLLTGCSGRDAVA ↓QGG 
Rv0559c MKGTKLAVVVGMTVAAVSLAAPAQA ↓DDY 
Rv0867c MSGRHRKPTTSNVSVAKIAFTGAVLGGGGIAMAAQATA ↓ATD 
Rv0999 MRPPLAPQFAADLLVKTVSTLRSSGAALGRLTTMRKAVLAVGSVCWLVGCSSGASS ↓TTA 
Rv1158c MPTIWTFVRAAAVLVGSSAALLTGGIAHA ↓DPA 
Rv1174c MRLSLTALSAGVGAVAMSLTVGAGVASA ↓DPV 
Rv1269c MTTMITLRRRFAVAVAGVATAAATTVTLAPAPANA ↓ADV 
Rv1352 MARTLALRASAGLVAGMAMAAITLAPGARA ↓ETG 
Rv1477 MRRNRRGSPARPAARFVRPAIPSALSVALLVCTPGLATA ↓DPQ 
Rv1804c MRVVSTLLSIPLMIGLAVPAHA ↓GPS 
Rv1810 MQLQRTMGQCRPMRMLVALLLSAATMIGLAAPGKA ↓DPT 
Rv1815 MVRLVPRAFAATVALLAAGFSPATASA ↓DPV 
Rv1845c MSALAFTILAVLLAGPTPALLA ↓RAT 
Rv1886c MTDVSRKIRAWGRRLMIGTAAAVVLPGLVGLAGGAATAGA ↓FSR 
Rv1906c MRLKPAPSPAAAFAVAGLILAGWAGSVGLAGA ↓DPE 
Rv1910c MAHAFHRFALAILGLALPVALVAYGGNGDSRKA ↓APL 
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Rv1926c MKLTTMIKTAVAVVAMAAIATFAAPVALA ↓AYP 
Rv1984c MTPRSLVRIVGVVVATTLALVSAPAGGRAAHA ↓DPC 
Rv2190 MRLDQRWLIARVIMRSAIGFFASFTVSSGVLAANVLA ↓DPA 
Rv2253 MSGHRKKAMLALAAASLAATLAPNAVA ↓AAE 
Rv2301 MNDLLTRRLLTMGAAAAMLAAVLLLTPITVPA ↓GYP 
Rv2576c MPAGVGNASGSVLDMTSVRTVPSAVALVTFAGAALSGVIPAIARA ↓DPV 
Rv2668 MRHWLIVLATLLVAAAGVAAANDVPRAWA ↓GDA 
Rv2693 MNANRTSAQRLLAQAGGVSGLVYSSLPVVTFVVASSA ↓AGL 
Rv2911 MRKLMTATAALCACAVTVSAGAAWA ↓DAD 
Rv3354 MNLRRHQTLTLRLLAASAGILSAAAFAAPAQA ↓NPV 
Rv3491 MNIRCGLAAGAVICSAVALGIALHSGDPARA ↓LGP 
Rv3668c MQTAHRRFAAAFAAVLLAVVCLPANTAAA ↓DDK 
Rv3705c MRIAAAVVSIGLAVIAGFAVPVADA ↓HPS 
Rv3759c MRMLRRLRRATVAAAVWLATVCLVASCANA ↓DPL 
Rv3803c MKGRSALLRALWIAALSFGLGGVAVAAEPTAKA ↓APY 
Rv3804c MQLVDRVRGAVTGMSRRLVVGAVGAALVSGLVGAVGGTATAGA ↓FSR 
 
a ↓ The experimentally identified signal peptidase I cleavage site. 
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Supplentary material 
 
Supplementary table 1. A detailed list of identified M. tuberculosis H37Rv culture filtrate proteins by 2D-PAGE combined with MALDI-TOF 
MS and liquid chromatography coupled with MS/MS.  
 
Supplementary table 2. List of predicted secreted or exported M. tuberculosis H37Rv culture filtrate proteins identified in this study, with their 
possible retention peptides.  
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Supplementary table 1. A detailed list of M. tuberculosis H37Rv culture filtrate proteins identified by 2D-PAGE combined with MALDI-TOF MS and 
liquid chromatography coupled MS/MS 
Gene 
number a
 
 
 
Theoretical 
molecular 
mass  
(kDa) c
 
Observed 
molecular 
mass 
(kDa) d
Theoretical 
isoelectric 
point  
(pI) e
 
Observed 
isoelectric 
point  
(pI) f
 
Identification 
method g
 
 
Sequence 
coverage h
Peptide sequence i
 
Fraction  
number j
 
Batch 
number k
 
 
Score 
 
  
Minimum 
significance 
score  
(p<0.05) 
Charge 
 
 
 
Rv0002 42.1 50 4.76 4.79 MS 7/20%  A 52 51  
Rv0009 19.2 17 5.81 6.28 MS 7/57%  A 89 51  
Rv0012 23.22/23.22  6.57/6.57  LC-MS/MS 1 IDSVHGRSVDTALAAMQR 6 A 17 11 3 
Rv0015c 43.34/- 31 10.33/- 4.88 MS 6/20%  A 54 51  
Rv0019c 10.33/-  8.38/-  LC-MS/MS 1 QGLVLQLTR 10 B 20 13 2 
Rv0040c 28.92/27.29  30 8.68/8.91 5.8 MS  8/37%  A 105 43  
     LC-MS/MS 7 ALDITLPMPPR 10 A,C 20 12 2 
     LC-MS/MS  WTQVPDPNVPDAFVVIADR 6 A,B,C 33 18 2 
     LC-MS/MS  ENDMTLNTSR 6 A 37 21 2 
     LC-MS/MS  HVIATSGADK 6 A 15 14 2 
     LC-MS/MS  LGNSVYTSNAQLVVYR 6 A,B,C 97 23 2 
     LC-MS/MS  LIGDFDPAEAITHGYIDSQK 6 A,B,C 51 21 2 
     LC-MS/MS  LLAWQTTNASMANFDGFPSSIIEGTYR 8 A 80 19 3 
Rv0054 17.35 20 5.12 5.2 MS 7/73%  A 143 51  
Rv0062 32.62/- 31.5 4.96/- 4.87 MS 9/64%  A 97 51  
Rv0063 46.21/46.21 35 6.81/6.81 6.83 MS  8/25%  A 54 51  
     LC-MS/MS 8 AMAFAAANNLK 7 A 67 22 2 
     LC-MS/MS  AYSVGGYVNYLEVNQPPAR 4 A,C 41 24 2 
     LC-MS/MS  DPAASGWEALSSALGGK 5 C 105 11 2 
     LC-MS/MS  ILATCPAGSGGSVAAAIVSAVGTQPTG- 7 A 21 20 3 
       TENHTFNYLDLVR      
     LC-MS/MS  VLQPDDGPQFATAK 7 A,C 64 22 2 
     LC-MS/MS  VTVTPATGLYAMHQVLAAAGR 3 A,C 15 12 3 
     LC-MS/MS  YFGPNLSR 4 A,C 42 22 2 
     LC-MS/MS  YLAVGNLNPSPLGYVGGSDVFTTITPA- 7 A 70 19 3 
       TAQGIASAVDAFPR      
Rv0064 103.44/102.95  6.26/6.38  LC-MS/MS 1 YELLSSGRK 5 A 21 13 1 
Rv0066 82.54  5.7  LC-MS/MS 1 VPDNLAELGR 3 A 40 19 2 
Rv0075 37.7  5.1  LC-MS/MS 1 ANRDHLAR 3 A 19 16 2 
Rv0116c 23.88/22.13  7.36/7.36  LC-MS/MS 1 TVVMDSR 10 A 19 13 2 
Rv0125 31.50/31.50 29 4.53/4.53 4.5 MS/MS 5 TQDVAVLQLR  A 64 51 1 
     LC-MS/MS  TQDVAVLQLR 10 A,C 53 10 2 
     LC-MS/MS  TGNVTLAEGPPA 8 A,C 18 11 2 
     LC-MS/MS  GAGGLPSAAIGGGVAVGEPVVAMGNSGGQGGTPR 8 A,C 73 12 3 
     LC-MS/MS  SGGGSPTVHIGPTAFLGLGVVDNNGNGAR 10 C 23 11 3 
     LC-MS/MS  APPALSQDR 6 A 26 11 2 
Rv0129c 32.02/32.02 32.5 4.99/4.99  5.6 MS  9/21%   A 80 51  
     LC-MS/MS 13 ADIQHVLNGATPPAAPAAPAA 8 A,C 18 10 2 
     LC-MS/MS  DTYAADGGR 10 A 51 21 2 
     LC-MS/MS  EMPAWLQANK 10 A,B,C 39 14 2 
     LC-MS/MS  FLEGLTLR 10 A,B,C 36 13 2 
     LC-MS/MS  FSRPGLPVEYLQVPSASMGR 8 A,B,C 43 16 3 
     LC-MS/MS  IWVYCGNGTPSDLGGDNIPAK 6 A,B,C 10 9 2 
     LC-MS/MS  LVANNTR 8 A 41 24 2 
     LC-MS/MS  NDPMVQIPR 5 A,C 36 22 2 
     LC-MS/MS  NGVFNFPPNGTHSWPYWNEQLVAMK 5 A,B,C 46 23 3 
     LC-MS/MS  RNDPMVQIPR 5 A 38 22 2 
     LC-MS/MS  TNQTFR 8 A 26 21 2 
     LC-MS/MS  VQFQGGGPHAVYLLDGLR 1 A,B,C 97 10 3 
     LC-MS/MS  WETFLTR 10 A,C 41 22 2 
Rv0140 13.76  4.17  LC-MS/MS 1 MSNRIVLEPSADHPITIEPTNR 3 A 18 17 3 
Rv0164 17.06/- 13 5.34/- 4.47 MS/MS 1 YPEWNEGVK  A 56 51 1 
Rv0170 34.19/34.61  7.93/8.50  LC-MS/MS 1 ALHLVDGGRR 3 A 11 11 3 
Rv0172 53.08/52.95  4.85/4.85   LC-MS/MS 1 TQVPTEWDELR 6 A 32 24 2 
Rv0173 38.81b  6.01b  LC-MS/MS 1 LLAYVGGRSEVLNR 10 A,C 12 13 2 
Rv0174 51.71/51.23  5.16/5.16  LC-MS/MS 2 GTVPSEIGPALDNSNR 8 A 28 13 2 
     LC-MS/MS  VTAVEPTDQGAR 6 A 54 23 2 
Rv0192 38.9  7.24  LC-MS/MS 1 LTVSDAVR 4 A 26 24 2 
Rv0203 10.27/10.34   6.23/6.29  LC-MS/MS 1 AHFEANPK 10 A 31 23 2 
Rv0211 67.25  4.68  LC-MS/MS 1 ALHSVGAPLEPGQK 3 A 33 17 3 
Rv0219 16.27/16.27  10.96/10.96  LC-MS/MS 1 AGCSRVDAIDEE 10 C 15 12 3 
Rv0237 37.67b 32 5.27b 5.2 MS 11/45%   A 76 51  
Rv0242c 46.83  6.4  LC-MS/MS 2 VVVVGGTPEAAASTNER 7 A 36 22 2 
     LC-MS/MS  GQTNYATTK 5 A 39 22 2 
Rv0244c 66.01 34 5.19 4.48 MS 6/21%   A 53 51  
Rv0265c 32.73b  5.43b  LC-MS/MS 1 AVLDAADVLIWMTESPEDEK 10 A 7 6 3 
Rv0283 55.94  7.32  LC-MS/MS 1 SPIDLADHAVTSGLGLGADVPAPR 10 A 20 19 3 
Rv0285 6.59/6.59   4.00/4.00  LC-MS/MS 2 AGVGVGESGASYLAGDAAAAATYGVVGG 8 A 67 23 3 
     LC-MS/MS  APVITAVVPPAADPVSLQTAAGFSA- 10 A 65 23 3 
       QGVEHAVVTAEGVEELGR      
Rv0287 9.7 10 5.99 6 MS/MS 3 SLLDAHIPQLVASQSAFAAK  A 86 51 1 
     LC-MS/MS  SLLDAHIPQLVASQSAFAAK 10 A 77 22 3 
     LC-MS/MS  HTIGQAEQAAMSAQAFHQGESSAAFQAAHAR 10 A,C 78 19 4 
     LC-MS/MS  VNTLLDVAQANLGEAAGTYVAADAAAASTYTGF 10 A 60 20 3 
Rv0291 43.48/42.59  40 5.17/5.30 4.7 MS 7/21%   A 65 51  
     LC-MS/MS 2 GEGQLVAIIDTGVQPGPR 5 B 36 19 2 
     LC-MS/MS  LVALSGTSYAAGYVSGVAALVR 5 B 35 19 3 
Rv0309 19.09/18.62  8.48/8.49  LC-MS/MS 2 MDVYQR 10 A 31 22 2 
     LC-MS/MS  HSVVMGVNK 10 A 27 23 2 
Rv0315 28.81/27.11  22 4.79/4.77 4.75 MS  6/36%   A 66 51  
     LC-MS/MS 9 EWPFNDPGYK 6 C 43 24 2 
     LC-MS/MS  FNCLAPGMWPAWWLSNDDPGR 9 C 13 9 3 
     LC-MS/MS  GGIGTTWEAR 9 A,C 41 23 2 
     LC-MS/MS  VFPVLNLAVGGSGGGDPATGSYPQEMLVDWVR 9 A,C 78 19 3 
     LC-MS/MS  QNVFLDGNSNLVLR 9 C 65 22 2 
     LC-MS/MS  SGEIDLIEWYGNGTWPSGTTVHANP- 9 A 44 17 4 
       DGTAFETCPIGVDGGWHNWR      
     LC-MS/MS  VTWNPSGMYFWLDYADGIEPYFSVPATGIEDLNEPIR 10 A 21 20 3 
     LC-MS/MS  WQVSNHR 9 A 44 22 2 
       TPIKNPVGFDRPQFFGQYR 9 C 20 14 2 
     LC-MS/MS  YFGGLVHGLWR 8 C 42 23 2 
Rv0340 18.35  4.53  LC-MS/MS 2 ANSLLDFVISLVR 7 A 38 22 2 
     LC-MS/MS  SIAEAHLTDVTR 8 A 33 28 2 
Rv0350 66.83 65 4.85 4.79 MS  6/36%   A 232 51  
     LC-MS/MS 7 NTTIPTKR 5 A 52 24 2 
     LC-MS/MS  MPAVTDLVK 5 A 24 23 2 
     LC-MS/MS  NQAVTNVDR 3 A 43 23 2 
     LC-MS/MS  YTAPEISAR 3 A 41 22 2 
     LC-MS/MS  NQAETLVYQTEK 3 A 54 21 2 
     LC-MS/MS  AALGGSDISAIK 3 A 42 23 2 
     LC-MS/MS  TTPSIVAFAR 3 A,C 34 23 2 
Rv0363c 36.54 37 5.49 6 MS 10/44%   A 74 51  
Rv0398c 19.16/19.16  17 5.36/5.36 5.4 MS  10/48%   A 97 51  
     LC-MS/MS 5 DVASVFLPLQR 7 A,C 33 22 2 
     LC-MS/MS  ISQQLFSFGDPTVQEVDGSDAAQFI- 10 A 32 18 4 
       TAAAAVADRDVASVFLPLQR      
     LC-MS/MS  VLGCQQNTAGSGAGFGAR 10 A,C 92 21 2 
     LC-MS/MS  ISQQLFSFGDPTVQEVDGSDAAQFITAAAAVADR 10 A 35 19 3 
     LC-MS/MS  RGEEGYFVLLAGTASDFCSAPNANYR 6 A 49 9 3 
Rv0402c 100.65/99.77  6.31/6.21  LC-MS/MS 1 VADLSTLTDQLQRMIDITQR 7 A 12 12 4 
Rv0408 72.94  5.2  LC-MS/MS 2 KIDTALELMDR 8 A 27 23 3 
     LC-MS/MS  LRDSPVAGR 3 A 17 17 2 
Rv0411c 32.87b 31 5.04b  5.25 MS  11/33%   A 91 51  
     LC-MS/MS 3 ILSAAER 3 A 16 15 2 
     LC-MS/MS  TMSITCER 8 A 18 12 2 
     LC-MS/MS  EIAPPPVIVSVVNWADCLVALQQR 1 A 28 11 3 
Rv0436c 27.55/26.03  10.01/10.06  LC-MS/MS 1 ILDAQSR 8 A 18 14 2 
Rv0446c 26.41/26.41  10.57/10.57   LC-MS/MS 1 GATPVQALRK 10 A 18 14 2 
Rv0453 -/49.88  -/4.59  LC-MS/MS 1 MPMLPGAWDLGTWDR 4 C 13 11 3 
Rv0455c 13.70/13.70 16 5.72/5.72 5.3 MS  5/41%   A 68 51  
     LC-MS/MS 2 DSTEDFPIPR 10 C 55 14 2 
     LC-MS/MS  DTSPVYYQR 10 A 33 22 2 
Rv0462 49.2 50 5.7 5.6 MS 11/30%   A 98 51  
     LC-MS/MS 1 ALPNEDADVSK 6 A 42 23 2 
Rv0472c 26.38  7.72  LC-MS/MS 1 MLAVMLR 2 A,C 21 15 2 
Rv0477 13.52/13.52 12.5 4.56/4.56 4.5 MSMS 4 LVDHTEWAQWGSLPSLR  A 75 51 1 
     LC-MS/MS  DPEADPGAGEANYGGPPSSPR 10 A 44 13 2 
     LC-MS/MS  VYPSQVGR 10 A 36 23 2 
     LC-MS/MS  LVDHTEWAQWGSLPSLR 9 A 27 12 3 
Rv0490 42.77/42.77  6.07/6.07  LC-MS/MS 1 SRATGGSGLGLAIVK 7 A 17 11 3 
Rv0501 41.06 32 10.38 5.2 MS 8/22%   A 54 51  
Rv0506 13.44/12.52  6.99/6.31  LC-MS/MS 1 IAYLDPDAR 9 A 29 19 2 
Rv0526 20.06
b 
19.66/19.30 18 
5.17b 
5.00/5.16 5.5 MS  11/60%   A 112 51  
     LC-MS/MS 3 GAGVSFLGIDVR 10 A 26 23 2 
     LC-MS/MS  VAEEEPSGR 10 A 59 24 2 
     LC-MS/MS  AEVSQLQR 4 A 45 24 2 
Rv0559c 9.75/9.75  7.01/7.01  LC-MS/MS 5 GTTQGQAFQFLGAAIDHYCPEHVGVLQR 9 A 73 12 4 
     LC-MS/MS  GVDGDAYK 10 A 30 21 2 
     LC-MS/MS  SATFLQR 4 A 24 23 2 
     LC-MS/MS  FGIYGPQDYNAWLAK 10 A 59 22 2 
     LC-MS/MS  DDYDAPFNNTIHR 10 A,C 27 10 2 
Rv0563 26.58/26.18  9.45/9.45  LC-MS/MS 1 IVRELATSAHQPMPR 6 C 14 10 3 
Rv0583c 21.83b  4.39b   LC-MS/MS 1 LLPESSR 9 A 14 13 2 
Rv0631c 119.5  6.39  LC-MS/MS 1 TRNHIAR 4 A 17 16 2 
Rv0674 24.28/24.28  7.02/7.02  LC-MS/MS 1 SADGYRLSDR 5 A 13 9 2 
Rv0677c 12.98/10.32 12 4.57/4.26 4.24 MS  5/61%   A 57 51  
     LC-MS/MS 2 ITVDGEVKDER 10 A 37 23 2 
     LC-MS/MS  VFADDPEPFDPK 9 C 15 10 2 
Rv0680c 10.33/10.33 9 4.65/4.65 4.6 MS/MS 1 NGDPFIWDR  A 56 51 1 
Rv0732 43.93/41.85  9.23/9.32  LC-MS/MS 1 FEELR 6 A 12 11 1 
Rv0774c 24.84/27.36  5.41/5.90  LC-MS/MS 1 ASGEDAGAMVLNELIPLLDTQR 6 A 24 10 2 
Rv0787 31.70/- 23 4.78/- 5.18 MS  6/31%   A 58 51  
     LC-MS/MS 1 ACQLGAPLQSPSVTDDEPTR 10 A 98 21 2 
Rv0835 20.83b 21 4.82b 4.83 MS  6/27%   A 52 51  
     LC-MS/MS 1 EPPEADTNVPGPCR 7 A 21 13 2 
Rv0838 24.98b 24 5.97b 5.78 MS  6/33%   A 105 43  
     LC-MS/MS 3 AAGLVDVR 9 A 40 25 2 
     LC-MS/MS  GVVPDAAIDLR 6 C 31 4 2 
     LC-MS/MS  SVDVTFASAQR 7 C 18 9 3 
Rv0843 35.72  5.87  LC-MS/MS 1 LIAAGTTR 8 A 33 24 2 
Rv0851c -/26.76  -/5.53  LC-MS/MS 1 GARVVLGDVDKPGLR 10 C 6 10 3 
Rv0867c 36.75/36.31  3.64/3.64  LC-MS/MS 2 ATDGEWDQVAR 4 A 12 12 2 
     LC-MS/MS  GLSNATPR 5 A 44 24 2 
Rv0876c 57.93  11.35  LC-MS/MS 1 VMPPTIDLVR 3 A 21 20 2 
Rv0884c 40.23 47.5 4.77 4.8 MS 8/37%   A 72 51  
Rv0928 35.84b 35 5.26b  4.8 MS 8/27%   A 56 51  
     LC-MS/MS 3 YPDSQVGTAVK 6 A 21 12 2 
     LC-MS/MS  SDESGTTDNFQR 7 A 36 22 2 
     LC-MS/MS  RPGSYPIVLATYEIVCSK 6 B 32 19 3 
Rv0932c 35.73b 35 4.76b  5.9 MS 5/30%   A 66 58  
     LC-MS/MS 2 SGTSDNFQK 6 A 20 9 2 
     LC-MS/MS  AFMQAAIGPGQEGLDQYGSIPLPK 6 B 20 17 3 
Rv0934 35.90b 32 4.82b  4.75 MS  9/37%   A 65 51  
     LC-MS/MS 6 ASFLDQVHFQPLPPAVVK 5 B 45 18 3 
     LC-MS/MS  DAATAQTLQAFLHWAITDGNK 5 B 29 21 2 
     LC-MS/MS  GLMNIALAISAQQVNYNLPGVSEHLK 5 B 37 18 3 
     LC-MS/MS  SDGSGDTFLFTQYLSK 6 B 24 17 2 
     LC-MS/MS  SDGSGDTFLFTQYLSKQDPEGWGK 5 B 63 17 3 
     LC-MS/MS  TWDDPQIAALNPGVNLPGTAVVPLHR 7 B 50 18 3 
Rv0982 48.69/48.69  7.23/7.23  LC-MS/MS 1 MALNLMDNAAKWSPPGGHVGVR 9 C 10 9 3 
Rv0996 35.97/36.16  4.62/4.60  LC-MS/MS 1 LGVENTR 9 A 15 14 2 
Rv0999 20.88
b 
20.30/20.02  
6.13b
6.07/6.08  LC-MS/MS 1 TTASTGDIAK 10 A 23 13 2 
Rv1037c* 9.8 10 4.48 4.6 MS/MS 2 NFQVIYEQANAHGQK  A 110 51 1 
     LC-MS/MS  TINYQFGDVDAHGAMIR 9 A 24 24 2 
Rv1038c* 11 10 5.17 5.2 MS 4/33%   A 59 51  
     LC-MS/MS 4 FEVHAQTVEDEAR 10 A,C 96 23 2 
     LC-MS/MS  FEVHAQTVEDEARR 9 A,C 53 18 4 
     LC-MS/MS  NIVNMLHGVR 9 A 51 22 2 
     LC-MS/MS  FMTDPHAMR 10 A 69 45 2 
Rv1050 -/29.46  -/10.41  LC-MS/MS 1 SGRIMNMSSVVGR 10 A 14 11 3 
Rv1074c 42.65 47 4.92 4.8 MS 11/45%  A 113 51  
Rv1075c 30.88/29.31  10.52/10.49  LC-MS/MS 1 ALAHTRGVR 7 A 11 9 2 
Rv1077 48.63 50 5.17 5.2 MS 8/28%  A 74 51  
Rv1098c 50.14  5.18  LC-MS/MS 1 TAANSFEAQAAR 6 A 35 23 2 
Rv1158c 18.54/15.12  4.23/4.56  LC-MS/MS 2 VDLPQLPYLPLQVPQQLSLPADLPALASGV- 4 A 9 6 4 
       IPAAPIAPTPPAPGAPALPPGPPSLLAALP      
     LC-MS/MS  DPAPAPAPAPNIPQQLISSAANAPQILQN- 10 A 23 10 3 
       LATALGATPPLSAPK      
Rv1161 136.92  6.67  LC-MS/MS 1 GVPVR 5 A 24 17 1 
Rv1166 63.48b  5.14b   LC-MS/MS 1 VENIDPQR 5 A 13 11 2 
Rv1174c 8.34/8.34   4.23/4.23  LC-MS/MS 3 NFLAAPPPQR 10 A,C 50 21 2 
     LC-MS/MS  DPVDAVINTTCNYGQVVAALNATDPGA- 2 A 70 10 4 
       AAQFNASPVAQSYLR      
     LC-MS/MS  AAMAAQLQAVPGAAQYIGLVESVAGSCNNY 10 A 37 12 3 
Rv1183 104.06/103.78  8.98/8.88  LC-MS/MS 2 GAQPNTSLADASISMSGYPVMLRDIR 9 A 14 9 3 
     LC-MS/MS  DNGTLDKVVGLAR 7 C 17 12 3 
Rv1186c 57.52  5.9  LC-MS/MS 1 HPSDSVVAGAVR 7 A 17 17 2 
Rv1197* 10.96  5.02  LC-MS/MS 1 MWASAQNISGAGWSGMAEATSLDTMAQMNQAF 10 A 32 20 2 
Rv1198 9.9 5 4.97 4.5 MS/MS 2 AQAGLLEAEHQAIIR  A 78 51 1 
     LC-MS/MS  AQAGLLEAEHQAIIR 10 A 73 23 2 
Rv1252c 17.71b  5.21b  LC-MS/MS 1 SEQPWNPEPLAGNYNECAQLSAVVIK 10 C 11 10 3 
Rv1269c 9.08/9.08 8 6.26/6.26 5.7 MS 3/32%  A 45 43  
Rv1270c 22.60b  4.93b  LC-MS/MS 7 DASVAGSQQADGVATTK 9 A 21 13 2 
     LC-MS/MS  GLANLLANLK 7 B 38 19 2 
     LC-MS/MS  ITGNSSADDIATLAGSR 7 B 92 18 2 
     LC-MS/MS  LAVTGDVPNLR 7 A,B 33 19 2 
     LC-MS/MS  LEGDISNTPQTVATGSATLLVGNK 7 B 20 18 3 
     LC-MS/MS  LEGDISNTPQTVATGSATLLVGNKSEDAK 7 B 22 17 3 
     LC-MS/MS  TVPTTVWIASDGSSHLVQIQIAPTK 7 B 26 18 3 
Rv1310 53  4.6  LC-MS/MS 1 NFGGTSVFAGVGER 3 B 19 18 3 
Rv1323 40.08 40 4.91 5 MS 11/35%  A 71 51  
Rv1352 9.98/9.98 11 4.63/4.63 4.58 MS/MS 2 TEGPSNPLILVFGR  A 127 51 1 
     LC-MS/MS  TEGPSNPLILVFGR 10 A,B,C 92 23 2 
     LC-MS/MS  ETGEQFPGDGVFLVGTDIAPGTYR 10 A 44 9 3 
Rv1371 55.12 10 9.44 4.33 MS 10/5%  A 55 51  
Rv1382 14.43/15.83  5.21/9.29  LC-MS/MS 1 AVLTRYPSGIMVER 8 A 18 15 2 
Rv1386 6.39/7.03   4.63/4.63  LC-MS/MS 2 SGVGVAESGASYAAR 3 A 36 12 2 
     LC-MS/MS  DALAAASYLSGGL 9 A 24 14 2 
Rv1415 46.01 42.5 5.46 4.75 MS 9/33%  A 53 51  
Rv1419  13.65/13.65  4.18/4.18  LC-MS/MS 2 WNLTDDR 10 A 44 23 2 
     LC-MS/MS  LQPCVNWISQHWTVQPDGLVK 9 C 12 11 3 
Rv1435c 15.22/15.22   3.76/3.76  LC-MS/MS 1 DALTDPAPAGGPVPGQPVLPGPSASAPAGAR 10 A 33 13 3 
Rv1436 35.95 35 5.19 5.25 MS 7/37%  A 52 51  
Rv1437 42.51 45 4.83 4.81 MS 9/36%  A 89 51  
Rv1438 27.4 30 5.54 5.66 MS 6/37%  A 53 51  
Rv1448c 40.72 50 4.87 4.88 MS 9/34%  A 101 51  
     LC-MS/MS 3 GQAGVANAR 5 A 29 23 2 
     LC-MS/MS  ALSEGHTYDAQIAELAAR 5 B 32 19 3 
     LC-MS/MS  TVTTDDVR 5 A 31 22 2 
Rv1449c 75.55  4.78  LC-MS/MS 1 EDVLTHTR 4 A 24 22 2 
Rv1454c 34.04 24 5.37 4.52 MS 12/72%  A 108 51  
Rv1475c 102.49 105 4.95 4.95 MS  32/44%  A 228 51  
     LC-MS/MS 6 IDTPGEADYYR 3 A 25 22 2 
     LC-MS/MS  SNLIGMGVIPLQFPEGK 3 A 30 23 2 
     LC-MS/MS  AVNDNDLSVTAVLSGNR 3 A 68 22 2 
     LC-MS/MS  NGGILQYVLR 3 A 35 23 2 
     LC-MS/MS  NEDGSNITK 2 A 27 23 2 
     LC-MS/MS  AVIAESFER 2 A 26 22 2 
Rv1477 45.72/45.72  6.07/6.07  LC-MS/MS 2 DANAAIAAAQHR 8 A 42 14 2 
     LC-MS/MS  DPQTDTIAALIADVAK 7 C 22 11 2 
Rv1488 37.88/37.88  6.15/6.15  LC-MS/MS 1 VARVELR 7 A 13 13 2 
Rv1498A 7.62  6.23  LC-MS/MS 2 ALDWFEVQSIR 5 B,C 71 18 2 
     LC-MS/MS  GHLVDGAVAHFQVTMK 5 B 26 18 3 
Rv1541c 20.01b  6.20b  LC-MS/MS 1 DACAQDTDPR 3 A 11 11 3 
Rv1729c 33.62  4.55  LC-MS/MS 1 TISNPFRCHGVDVDLASLVYTGPR 10 B 21 18 3 
Rv1759c -/71.30  -/5.07  LC-MS/MS 1 AGLYGNGGDGGAGGDGATSGKGGAG- 10 A 13 10 3 
       GNAVVIGNGGNGGNAGK      
Rv1784 101.47  5.46  LC-MS/MS 1 DVPVKPGR 4 A 17 16 2 
Rv1793 10 9 4.76 4.45 MS/MS 1 AQAASLEAEHQAIVR  A 80 51 1 
     LC-MS/MS  AQAASLEAEHQAIVR 7 A 68 19 3 
Rv1804c 8.93/8.93 8.5 6.29/6.29 6.2 MS 3/54%  A 49 43  
Rv1810 8.43/8.43  4.50/4.50  LC-MS/MS 3 FAAIASGAYCPEHLEHHPS 10 A 39 12 2 
     LC-MS/MS  DPTGDDAAFLAALDQAGITYADPGHAITAAK 10 A 97 9 3 
     LC-MS/MS  DYNPGLTMDSAAK 10 A 31 13 2 
Rv1812c 40.00/39.93  6.49/6.49  LC-MS/MS 1 TGVSVAAVSPGGVTLSSGERLAAATVVWCAGMR 8 A 12 6 4 
Rv1815 20.18/20.18  24 5.33/5.33 5.4 MS/MS 5 QDNHVCTLGYVDPALK  A 121 51 1 
     LC-MS/MS  QDNHVCTLGYVDPALK 9 A 43 16 3 
     LC-MS/MS  STSEQVHADLGVTPLA 10 A 50 21 3 
     LC-MS/MS  DNTPSGSTVATHELIADYEAIVLADDVTASNILPSGR 10 A 80 21 3 
     LC-MS/MS  DPVLVFPGMEIR 10 A,C 54 13 2 
     LC-MS/MS  GDSGGPVYLAPDGGPAQIVGIFNSVWGGFPAAVSWR 10 A 43 20 2 
Rv1827 17.25 20 4.29 4.2 MS 4/39%  A 52 51  
Rv1833c 32.15  9.34  LC-MS/MS 1 TIIPR 6 A 19 19 1 
Rv1837c 80.4 75 5.3 5.5 MS 23/37%  A 143 76  
Rv1845c 27.39/30.60  11.66/11.78  LC-MS/MS 1 RATWPLR 1 C 13 12 2 
Rv1860 28.78/26.85 37 4.52/4.64 4.4 MS/MS 9 TTGDPPFPGQPPPVANDTR  A 65 51 1 
     LC-MS/MS  TTGDPPFPGQPPPVANDTR 4 A,B,C 69 21 2 
     LC-MS/MS  ALAESIRPLVAPPPAPAPAPAEPAPAP- 6 A,B 41 19 4 
       APAGEVAPTPTTPTPQR      
     LC-MS/MS  FSDPSKPNGQIWTGVIGSPAANAPDAGPPQR 7 A,B,C 45 12 3 
     LC-MS/MS  IDNPVGGFSFALPAGWVESDAAHFDYGSALLSK 7 A 27 11 3 
     LC-MS/MS  INQETVSLDANGVSGSASYYEVK 5 A,B 55 9 2 
     LC-MS/MS  LYASAEATDSKAAAR 5 B 20 18 3 
     LC-MS/MS  LGSDMGEFYMPYPGTR 4 A,B,C 51 10 2 
     LC-MS/MS  LYASAEATDSK 5 A,B 65 23 2 
     LC-MS/MS  WFVVWLGTANNPVDK 4 A,B,C 67 13 2 
Rv1869c 41.61/42.11  4.92/4.93  LC-MS/MS 1 YDKLLLATGSAPR 4 C 11 12 2 
Rv1876 18.34 18 4.5 4.48 MS 12/74%  A 145 51  
Rv1884c 11.21/-  8.01/-  LC-MS/MS 1 EQQIAVANR 5 A 32 23    2 
Rv1886c 30.66/30.66 30 4.87/4.87 4.62 MS  8/41%  A 83 51  
     LC-MS/MS 10 AGCQTYKWETFLTSELPQWLSANR 8 A,B 57 20 3 
     LC-MS/MS  FQDAYNAAGGHNAVFNFPPNGTHSWEYWGAQLNAMK 10 A 36 20 4 
     LC-MS/MS  FQDAYNAAGGHNAVFNFPPNGTHSWEYWGAQLNAMKPDLQR 8 A 52 16 4 
     LC-MS/MS  FSRPGLPVEYLQVPSPSMGR 8 A,B,C 54 22 3 
     LC-MS/MS  LWVYCGNGTPNELGGANIPAEFLENFVR 8 A,B 41 13 3 
     LC-MS/MS  NDPTQQIPK 4 A 30 13 2 
     LC-MS/MS  VQFQSGGNNSPAVYLLDGLR 1 A,B,C 42 18 3 
     LC-MS/MS  WETFLTSELPQWLSANR 8 A,B,C 32 19 2 
     LC-MS/MS  AADMWGPSSDPAWER 6 A,B,C 50 12 2 
     LC-MS/MS  AADMWGPSSDPAWERNDPTQQIPK 6 B 23 17 3 
Rv1887 39.53  5.85  LC-MS/MS 1 VTSGEALTEPNPPEEQPNASAPQQDR 9 A 41 23 3 
Rv1891 -/11.92  -/4.56  LC-MS/MS 1 GWQPGWFTGAGFFPPEP 10 A 16 12 2 
Rv1899c 32.36b  9.79b  LC-MS/MS 1 HAGGVAAAIAR 1 C 12 13 2 
Rv1906c 12.56/12.56  4.68/4.68  LC-MS/MS 2 KPQVVTIEPTDK 6 A 70 10 2 
     LC-MS/MS  DPEPAPTPK 10 A 38 12 2 
Rv1908c 80.7 45 5.13 5.5 MS  6/25%  A 61 51  
     LC-MS/MS 2 ALVEVYGADDAQPK 4 A 37 23 2 
     LC-MS/MS  SSYGTGTGK 3 A 41 25 2 
Rv1910c 17.57/16.49  5.71/5.38  LC-MS/MS 2 FTLYHLPAVPPLAGLAGTQAAR 10 A 28 22 3 
     LC-MS/MS  APLAPKAAALGRSMPETPTGDVLTISSPAFADGAP 10 A 28 22 3 
Rv1911c 17.57b  5.30b  LC-MS/MS 2 FTLYHLPVALQLPPGATGVQAAQAIAQAASGQAR 10 A 52 21 4 
     LC-MS/MS  QGYFGPCPPAGTGTHHYR 6 A 43 10 3 
Rv1926c 13.66/13.66 10.5 4.50/4.50 4.6 MS  5/52%  A 63 51  
     LC-MS/MS 7 GSVTPAVSQFNAR 10 A,B,C 50 10 2 
     LC-MS/MS  IYFDVTGPSPTIVAMNNGMEDLLIWEP 10 A 50 23 2 
     LC-MS/MS  LGSELTMTDTVGQVVLGWK 10 A,B,C 51 19 2 
     LC-MS/MS  SSTAVIPGYPVAGQVWEATATVNAIR 10 A,B,C 63 17 3 
     LC-MS/MS  SSTAVIPGYPVAGQVWEATATVNAIRGSVTPAVSQFNAR 10 A 35 21 3 
     LC-MS/MS  TADGINYR 10 A 33 22 2 
     LC-MS/MS  VLWQAAGPDTISGATIPQGEQSTGK 10 A,B,C 63 20 3 
Rv1932 16.89 17 4.37 4.34 MS 7/61%  A 67 51  
Rv1980c 22.43/22.43 15 4.60/4.60 4.6 MS  5/26%  A 61 51  
     LC-MS/MS 10 AFDWDQAYR 6 A,B,C 26 16 2 
     LC-MS/MS  EAPYELNITSATYQSAIPPR 7 A,B,C 68 21 2 
     LC-MS/MS  FLSAATSSTPR 9 A 35 23 2 
     LC-MS/MS  GTDTGQACQIQMSDPAYNINISLPSYYPDQK 6 C 41 17 3 
     LC-MS/MS  GTQAVVLK 10 A 23 16 2 
     LC-MS/MS  KPITYDTLWQADTDPLPVVFPIVQGELSK 10 A 13 11 3 
     LC-MS/MS  QTGQQVSIAPNAGLDPVNYQNFAVTNDGVIF- 10 A 43 15 4 
       FFNPGELLPEAAGPTQVLVPR      
     LC-MS/MS  SLENYIAQTR 6 A,B,C 42 22 2 
     LC-MS/MS  VYQNAGGTHPTTTYK 10 A 76 22 3 
     LC-MS/MS  DKFLSAATSSTPR 6 A,C 41 12 3 
Rv1984c 19.01/18.66  4.85/4.69  LC-MS/MS 4 ASASNGSDDASAHIQR 7 A 76 24 2 
     LC-MS/MS  GTHQASGLGDVGEAFVDSLTSQVGGR 8 C 36 21 3 
     LC-MS/MS  DPCSDIAVVFAR 10 A 35 22 2 
     LC-MS/MS  SIGVYAVNYPASDDYR 8 C 73 10 2 
Rv2006 14.57  6.25  LC-MS/MS 1 RLQVAGVR 4 A 30 23 2 
Rv2060 8.03/10.28  11.42/11.88  LC-MS/MS 1 GVPVR 5 A 24 17 1 
Rv2068c 30.02b 23 5.26b 5.1 MS  6/42%   74 51  
     LC-MS/MS 2 AGGGYDAEPR 9 A 32 23 2 
     LC-MS/MS  LITYTSDDIR 3 A 44 11 2 
Rv2074 15 12.5 9.5 4.47 MS 5/33%  A 55 51  
Rv2080 17.34b 15 5.19b 4.72 MS/MS 1 QIVAAADLQAVR  A 76 51 1 
Rv2110c 30.3 24 4.65 4.7 MS 8/40%  A 77 51  
Rv2140c 18.63 18 5.41 5.32 MS  5/76%  A 156 51  
     LC-MS/MS 1 TTSPDPYAALPK 10 A 34 22 2 
Rv2190c 35.71/35.71  5.74/5.74  LC-MS/MS 1 DPADDALAK 6 A 20 15 2 
Rv2192c 37.7  6.4  LC-MS/MS 1 HAAAVR 3 A 12 9 2 
Rv2200c 35.12/35.32  5.76/5.62  LC-MS/MS 1 GELAPQPVG 7 C 11 10 2 
Rv2201 70.21/70.21  6.45/6.45  LC-MS/MS 1 SFSGAQLR 2 C 10 9 2 
Rv2220 53.57 57 5.4 5 MS  5/45%  A 53 51  
     LC-MS/MS 1 IPITGSNPK 6 A 28 22 2 
Rv2224c 52.65b  5.38b  LC-MS/MS 1 GVASSRPAIWCNSDADNDRLR 10 A 17 12 2 
Rv2236c 33 25 10.85 5.3 MS 4/20%  A 55 51  
Rv2241 100.18  5.84  LC-MS/MS 1 IVPIIPDEAR 2 A 18 15 2 
Rv2251 44.02/47.37  5.79/5.98  LC-MS/MS 1 ATLDPAGILNPGKLIP 10 A 20 13 2 
Rv2253 15.21/15.14 14 5.59/5.59 6 MS  6/62%  A 47 43  
     LC-MS/MS 5 TGTSMAANRPEYPHK 10 A 13 11 3 
     LC-MS/MS  ANYTFSSR 10 A 50 24 2 
     LC-MS/MS  NEFIPRPIEYTWNGTQWVR 7 A,C 35 10 3 
     LC-MS/MS  SITAYTPGQYGILTGVFHTDIASGTCK 7 A 29 13 3 
     LC-MS/MS  GNVDMPVSAKPIVG 7 A 39 13 2 
Rv2299 72.96  4.51  LC-MS/MS 1 LRIEALR 4 A 18 18 2 
Rv2301 20.62/19.67 21 4.96/4.96 5.5 MS/MS 3 FEPPGIGTVGNAFVSALR  A 92 51 1 
     LC-MS/MS  FEPPGIGTVGNAFVSALR 8 A,C 78 21 2 
     LC-MS/MS  ACPDAEVVFAR 6 A 30 16 2 
     LC-MS/MS  GRFEPPGIGTVGNAFVSALR 10 A,B 78 21 3 
Rv2314c 48.71 50 4.93 4.96 MS 10/23%  A 61 51  
Rv2334 32.75 32.5 5.2 52 MS 11/53%  A 100 51  
Rv2346c 9.9 8 4.76 44.2 MS/MS 2 AQAGLLEAEHQAIVR  A 81 51 1 
     LC-MS/MS  AQAGLLEAEHQAIVR 7 A 99 18 2 
     LC-MS/MS  DVLAAGDFWGGAGSVACQEFITQLGR 9 A 103 20 3 
Rv2376c 14.74/11.61 12 5.10/5.51 4.82 MS/MS 3 GSLVEGGIGGTEAR  A 71 51 1 
     LC-MS/MS  GSLVEGGIGGTEAR 9 A,B,C 69 18 2 
     LC-MS/MS  ASAMELLQAAGN 9 A,B 17 12 2 
     LC-MS/MS  AAEHGDLPLSFSVTNIQPAAAGSATADVSVSGPK 10 A 32 22 3 
Rv2401 11.1 15 5.17 4.28 MS 4/33%  A 54 51  
Rv2430c 21.98 27 4.77 4.98 MS/MS 2 APPPIAHSTVLVAPVSPSTASSR  A 91 51 1 
     LC-MS/MS  APPPIAHSTVLVAPVSPSTASSR 9 A 40 18 3 
     LC-MS/MS  SLDVEMTAVQR 9 A 44 22 2 
Rv2431c 10.6 10.8 5.76 5.23 MS  4/69%  A 58 51  
     LC-MS/MS 1 YATAEADNIK 10 A 54 21 2 
Rv2445c 14.5 17 5.34 5.26 MS 6/53%  A 65 51  
Rv2450c 14.78/14.78  4.12/4.12  LC-MS/MS 1 VAENVLR 10 A 17 14 2 
Rv2465c 17.27 15.5 6.14 6.2 MS 6/40%  A 70 51  
Rv2469c 21.94/20.99  9.86/9.73  LC-MS/MS 1 ADTVDHVVPR 7 C 16 12 2 
Rv2544 20.74b  5.25b  LC-MS/MS 1 FNDDSYGQDFYRNGSLCK 3 A 13 11 3 
Rv2563 31.11/31.41  8.39/6.80  LC-MS/MS 1 TVDSMGVDAFVVK 1 C 16 14 2 
Rv2575 30.8  4.93  LC-MS/MS 1 IQQQTTGR 9 A 33 24 2 
Rv2576c 11.56/11.56  4.93/4.93  LC-MS/MS 3 YMITLHTPIAGGQPLVYTATLANPSQWAIVTASGGLR 10 A 44 19 3 
     LC-MS/MS  DPVGHQVTYTVTTTSDLMANIR 10 A,C 46 10 3 
     LC-MS/MS  YMSADPPSMAAFNADSSK 10 C 35 21 2 
Rv2585c 55.43b  4.96b  LC-MS/MS 1 ALALCVPR 1 C 13 6 4 
Rv2631 45.52 50 6.99 4.95 MS 11/21%  A 53 51  
Rv2668 16.22/15.31 25.5 4.90/4.87 4.67 MS  6/39%  A 66 51  
     LC-MS/MS 5 GDAPIGHIGDTLR 10 A 40 13 3 
     LC-MS/MS  DPVSVVVLLDEK 10 A 63 25 2 
     LC-MS/MS  GGVYWDAYRDPVSVVVLLDEK 10 A 40 22 3 
     LC-MS/MS  VDTGTYVADVTVSSVVPVDPPPGFGYTR 10 A 67 20 3 
     LC-MS/MS  SFPDSSVTR 10 A 41 23 2 
Rv2672 51.15b 55 4.82b 4.81 MS  19/54%  A 169 51  
     LC-MS/MS  SGDMNLLSALINR 6 A 30 23 2 
Rv2693c 17.10/20.10  9.62/10.01  LC-MS/MS 1 AGLLPAIGFALSMAGLILLWRLLR 10 A 13 12 3 
Rv2721c 68.94/68.94 35 4.42/4.42 4.68 MS  15/28%  A 108 51  
     LC-MS/MS 2 AAGGAAGPLGAK 6 A 40 22 2 
     LC-MS/MS  EFTTVPAVLAEQLK 6 A 21 13 2 
Rv2766c 22.73/24.19  5.14/5.42  LC-MS/MS 1 VNAICPGVVRTR 2 A 17 14 2 
Rv2799 19.89/17.11 23 5.24/5.22 5.4 MS  7/33%  A 67 51  
     LC-MS/MS 4 ANDLVPYYR 10 C 30 21 2 
     LC-MS/MS  DIPFDVIQR 10 A,C 20 12 2 
     LC-MS/MS  LGLAYTPPEAEEGLR 10 A,C 81 22 2 
     LC-MS/MS  TYAQTLPPDAIETTIAGHR 10 A,C 14 12 3 
     LC-MS/MS  AAQYWVR 10 A 22 13 2 
Rv2823c 90.74  6.7  LC-MS/MS 1 WVYFLTR 4 A,C 33 18 2 
Rv2831 26.63 30 5.82 5.75 MS  12/53%  A 157 51  
     LC-MS/MS  TSGDTIAANR 9 A 33 23 2 
Rv2848c 44.05/45.55  5.96/6.11  LC-MS/MS 1 FVAHAACNTPRA 4 C 14 13 2 
Rv2873 19.80b 17 4.67b  4.38 MS/MS 2 IDGTHQTLQGADLTVIGAR  A 98 51 1 
     LC-MS/MS  LPAATIDQLK 10 A 25 23 2 
Rv2874 71.16/71.16  9.64/9.64  LC-MS/MS 1 CGYHSHLTGGEFDVNR 6 A 5 3 4 
Rv2875 16.31/16.31 16.7 4.31/4.31 4.36 MS/MS 5 QTLQGASVTVTGQGNSLK  A 57 51  
     LC-MS/MS  QTLQGASVTVTGQGNSLK 8 A 26 23 2 
     LC-MS/MS  LPASTIDELKTNSSLLTSILTYHVVAGQTSPANVVGTR 10 A 22 20 4 
     LC-MS/MS  LPASTIDELK 10 A 22 20 2 
     LC-MS/MS  VGNADVVCGGVSTANATVYMIDSVLMPPA 10 A 24 20 3 
     LC-MS/MS  TNSSLLTSILTYHVVAGQTSPANVVGTR 7 A 44 10 3 
Rv2878c 14.62/14.62 12.5 4.57/4.57 4.2 MS  5/38%  A 55 51  
     LC-MS/MS 4 ADGTSTFVNNPTAAMSQDELSGR 10 A,B,C 48 22 3 
     LC-MS/MS  ADVGAMQSFVSK 10 A,B,C 70 22 2 
     LC-MS/MS  YNLNFTNLNDADGVIWAR 10 A,B,C 43 11 2 
     LC-MS/MS  YNVPWQPAFVFYR 9 A,B,C 54 13 2 
Rv2905 31.18b  4.96b  LC-MS/MS 1 YGLRSTAPPSDGR 7 C 14 11 3 
Rv2911 28.38
b  
27.62/27.30 22 
4.75b 
4.75/4.75 4.7 MS  9/40%  A 54 51  
     LC-MS/MS 6 AATLGATSTHATTPSGLDGPGGSGASTAHDLVVIFR 7 B 20 17 4 
     LC-MS/MS  DQNVAHPPASTIK 6 A 54 22 2 
     LC-MS/MS  KTFVGAAAR 8 A 36 24 2 
     LC-MS/MS  VLLALVALDELDLNSTVVADVADTQAECNCVGVKPGR 1 A 65 19 4 
     LC-MS/MS  YPGAIGGK 8 A 51 23 2 
     LC-MS/MS  QLLDGLLLVSGNDAANTLAHMLGGQDVTVAK 1 A 60 11 4 
Rv2945c 22.36b 13 4.89b 5.3 MS 7/48%  A 62 51  
Rv2994 43.49/42.58  11.22/11.23   LC-MS/MS 1 CHAWPNGPR 7 A 18 12 2 
Rv3004 7.60/8.70  10.61/11.32  LC-MS/MS 2 LRTLADER 9 A 14 14 2 
     LC-MS/MS  WDDIDGLRFHR 8 A 15 12 2 
Rv3006 36.41b 33 4.71b 4.61 MS  9/36%  A 75 51  
     LC-MS/MS 1 LAPSTGAVTGEPDVVR 7 A 60 23 2 
Rv3016 20.23b 22 4.56b 4.38 MS/MS 1 TTFQDRPDGSLISEAAAAYR   61 51 1 
Rv3031 57.79  7.2  LC-MS/MS 1 NRLLSESER 3 A 29 22 2 
Rv3033 15.32/15.32  4.73/4.73  LC-MS/MS 1 VGARPDSVTCPDNLKGVEGAK 7 A 35 10 3 
Rv3036c 22.08/20.94  4.91/4.91  LC-MS/MS 4 DGFVNVAQGSPLR 7 A,B,C 78 19 2 
     LC-MS/MS  DQPYQMDATSEQHSSGQPPQATR 10 A,C 60 21 3 
     LC-MS/MS  FFQDLGGAHPSTWYK 1 A,B 42 16 2 
     LC-MS/MS  AFNYNLATSQPITFDTLFVPGTTPLDSIYPIVQR 10 A 36 19 3 
Rv3044 35.20b 27 5.09b  4.97 MS 15/32%  A 130 51  
     LC-MS/MS 3 AAAAADPGPPTRPAHNAAGVSPEMVQVPAEAQR 3 A 33 6 4 
     LC-MS/MS  IAAVDALITGFAEHATQVGTK 4 A,C 68 13 3 
     LC-MS/MS  AYIEIGTTAADLAK 3 A 34 12 2 
Rv3106 46.76/46.76  5.37/5.37  LC-MS/MS 1 AAGEPHGRPR 4 A 13 11 2 
Rv3111 17.84 32 8.76 5.26 MS 6/29%  A 52 51  
Rv3158 48.68/52.08  7.97/9.25  LC-MS/MS 1 LLSQEAAMK 4 C 14 11 2 
Rv3193c 103.24/103.24  8.53/8.53  LC-MS/MS 2 LDEAITK 2 A 17 12 2 
     LC-MS/MS  AVVLARLR 4 A 17 12 2 
Rv3194c 32.14/32.03  5.05/5.05  LC-MS/MS 1 VGQIGGITHK 3 A 13 6 2 
Rv3201c 112.33/112.33   5.91/5.91  LC-MS/MS 2 LAWAALR 4 A 16 14 2 
     LC-MS/MS  AEADGVKPPTAAVLVR 3 A 19 10 3 
Rv3240c 105.98  5.09  LC-MS/MS 1 FLGLQVGVILATMTPDERR 1 A 21 16 3 
Rv3244c 59.58b 57 5.12b 5.9 MS  11/24%  A 82 51  
     LC-MS/MS 3 IPVDSTAVASR 5 A 44 24 2 
     LC-MS/MS  MPEQTAAAVSR 5 A 51 23 2 
     LC-MS/MS  NTLYFADPTGK 9 A,C 17 13 2 
Rv3248c 54.32  4.85  LC-MS/MS 1 IADLSLADFGR 6 A 32 23 2 
Rv3267 48.06/47.79 50 4.87/4.87 4.82 MS  10/30%  A 59 51  
     LC-MS/MS 1 ADDLGAQQVAK 10 A 20 14 2 
Rv3310 28.03/27.14 25 5.40/5.40 5.55 MS/MS 2 TNNSLLVVTWDEDDGSSR  A 90 51 1 
     LC-MS/MS  SQAAIIGNK 9 A 27 24 2 
Rv3354 9.70/9.70  3.72/3.72  LC-MS/MS 2 ALGQSVCPILAEPGGSFNTAVASVVAR 10 A 28 13 3 
     LC-MS/MS  NPVDDAFIAALNNAGVNYGDPVDAK 10 A 76 13 3 
Rv3356c 29.48 32 5.97 6.2 MS 8/32%  A 75 51  
Rv3369 15.7  5.69  LC-MS/MS 2 FGLTEAIAAYSTR 10 B 69 19 2 
     LC-MS/MS  LTSDLYGWLTTVAR 9 B 47 18 2 
Rv3397c 33.14  7.37  LC-MS/MS 1 MEIDWTGCRDFDELIVYCR 7 A 8 6 4 
Rv3402c -/42.90  -/6.45  LC-MS/MS 1 TGMADAGVR 10 A 19 10 2 
Rv3413c 31.24  4.52  LC-MS/MS 2 QDLINEVNLLNTK 7 A 40 22 2 
     LC-MS/MS  VEQMIAQGQWAEAQDELAEVSSTVQAVTDGSR 10 A 58 41 3 
Rv3418c 10.7  4.62  LC-MS/MS 5 IPLDVAEGDTVIYSK 1 B 19 19 2 
     LC-MS/MS  RIPLDVAEGDTVIYSK 9 B 32 19 3 
     LC-MS/MS  VNIKPLEDKILVQANEAETTTASGLVIPDTAK 9 A 69 16 4 
     LC-MS/MS  YGGTEIKYNGEEYLILSAR 9 A 36 20 3 
     LC-MS/MS  YNGEEYLILSAR 10 A 48 19 2 
Rv3428 45.46  9.19  LC-MS/MS 1 ERVTVPR 3 A 19 19 2 
Rv3484 49.50/48.03 48 4.72/4.68 4.61 MS 9/23%  A 78 51  
Rv3485c 31/31  5.98/5.98  LC-MS/MS  VCTPLPR 8 C 20 19 2 
Rv3491 17.40/17.40 17 5.47/5.47 5.5 MS/MS  LGPPPDGSYSFNQAGVSGVTWTITALCDQPSGTR  A 46 43 3 
     LC-MS/MS 4 NMNDYSDPIVWAFNCALNVVSTTPQQITR 10 A 88 19 3 
     LC-MS/MS  LQNFSGR 10 A 23 22 2 
     LC-MS/MS  QPFSLQLIGPPPSPVQR 10 A,C 60 12 2 
Rv3495c 39.14b  4.80b  LC-MS/MS 1 ALDTLPDAVR 10 A 12 11 2 
Rv3509c 52.07 64 4.76 4.7 MS 16/40%  A 116 51  
Rv3572 16.29/16.22 13 4.75/4.75 4.55 MS  4/30%  A 55 51  
     LC-MS/MS 3 AGGSDVITTVYFGEGPPDK 10 A,C 9 7 2 
     LC-MS/MS  LAYLDAHATSQFER 8 A,C 24 22 3 
     LC-MS/MS  TPDGPTGFPPGLWAR 10 A,C 58 22 2 
Rv3584 15.76b  8.11b  LC-MS/MS 4 IQAVQTSDFIQPGK 7 A 23 13 2 
     LC-MS/MS  LTINNVLLR 7 A 67 7 2 
     LC-MS/MS  AVDLVLVAVNQSPDVSDR 7 A 58 12 2 
     LC-MS/MS  LPASGMLFVGTPDGQIVAPGPLPSNQAAK 7 A 24 10 3 
Rv3587c 22.18/22.18 32 5.79/5.79 4.91 MS  7/32%  A 82 51  
     LC-MS/MS 5 DVGAAVLAAYVYSLDNK 6 A,B 21 13 2 
     LC-MS/MS  DVGAAVLAAYVYSLDNKR 5 A,B,C 98 22 3 
     LC-MS/MS  EGDDCPDSTLAVK 7 A 35 22 2 
     LC-MS/MS  GLTNAPQYYVGDQPK 10 A,B,C 25 11 2 
     LC-MS/MS  TFSPGEQVTTAVTWTGMGS 10 A 52 12 2 
Rv3627c 43.89/41.33  5.71/4.96  LC-MS/MS 1 SRTPALDAGR 10 A 12 11 2 
Rv3629c 34.21/36.57  9.41/8.80  LC-MS/MS 1 WIEVPFAR 7 A 12 11 2 
Rv3668c 20.99
b 
20.18/20.18  
4.63b 
4.63/4.63  LC-MS/MS 4 VTPVAVFNGFAINGIGPDPSFGQIACK 10 A 18 10 3 
     LC-MS/MS  DDKLPLGGGAGIVVNGDTMCTLTTIGHDK 10 A 22 11 4 
     LC-MS/MS  YIPLHTPAVVMSINADLADINAK 6 A 72 10 3 
     LC-MS/MS  NRPGAGFVPVPA 6 A 28 12 2 
Rv3671c 36.45/- 25 6.38/- 4.45 MS 5/21%  A 52 51  
Rv3682 81.94/80.38 50 5.26/5.20 5.1 MS  12/20%  A 60 51  
     LC-MS/MS 1 LKDAGFQVADQTNSVNSSAK 10 A 25 21 3 
Rv3693 42.92/42.92  11.30/11.30  LC-MS/MS 1 RVVIVLDTGR 9 C 14 10 2 
Rv3705c 19.99/19.99  4.91/4.91  LC-MS/MS 3 QAVGVFASNDAADR 7 A,C 31 22 2 
     LC-MS/MS  HPSEPGVVSYAVLGK 10 A,C 41 12 2 
     LC-MS/MS  CFVQTR 10 A 27 21 2 
Rv3710 70.11  5.2  LC-MS/MS 1 GGVAYIK  A 23 22 2 
Rv3722c 47.34 40 5.63 5.65 MS  9/26%  A 69 51  
     LC-MS/MS  HQQILAPK 5 A 29 23 2 
Rv3725 -/30.11  -/9.53  LC-MS/MS 1 CPIPR 7 A 31 23 2 
Rv3759c 30.46
b 
30.10/30.10  
5.20b 
5.20/5.20  LC-MS/MS 1 DPLGSATGSVK 8 A 12 11 2 
Rv3760 5.56/5.56  12.60/12.60  LC-MS/MS 1 KTHAAALR 4 A 15 11 2 
Rv3803c 28.48/27.81 25 5.52/5.51 5.5 MS  9/41%  A 58 51  
     LC-MS/MS 9 DIPVAFLAGGPHAVYLLDAFNAGPDVSNW- 9 A 48 6 4 
       VTAGNAMNTLAGK      
     LC-MS/MS  GISVVAPAGGAYSMYTNWEQDGSK 10 A 43 23 2 
     LC-MS/MS  GLAPGGHAAVGAAQGGYGAMALAAFHPDR 9 A,B,C 21 11 4 
     LC-MS/MS  MFYNQYR 9 A,C 36 22 2 
     LC-MS/MS  QWDTFLSAELPDWLAANR 6 A,B,C 58 21 2 
     LC-MS/MS  SVGGHNGHFDFPASGDNGWGSWAPQLGAMSGDIVGAIR 9 A,C 39 19 4 
     LC-MS/MS  VWVWSPTNPGASDPAAMIGQAAEAMGNSR 9 A,B,C 40 21 3 
     LC-MS/MS  APYENLMVPSPSMGR 10 A,C 34 3 2 
     LC-MS/MS  WHDPWVHASLLAQNNTR 6 A,C 38 10 3 
Rv3804c 32.34/31.65 30 5.32/5.32 5.6 MS  7/21%  A 58 43  
     LC-MS/MS 11 ALGATPNTGPAPQGA 8 A,C 20 12 2 
     LC-MS/MS  ASDMWGPK 8 A 48 24 2 
     LC-MS/MS  EDPAWQR 4 A 26 23 2 
     LC-MS/MS  FLEGFVR 6 A,B,C 25 12 2 
     LC-MS/MS  LIANNTR 10 A 30 24 2 
     LC-MS/MS  NDPLLNVGK 10 A,C 33 22 2 
     LC-MS/MS  VQFQSGGANSPALYLLDGLR 6 A,B,C 36 23 3 
     LC-MS/MS  VWVYCGNGKPSDLGGNNLPAK 5 A,B,C 30 21 3 
     LC-MS/MS  WETFLTSELPGWLQANR 6 A,B,C 27 21 2 
     LC-MS/MS  AGCQTYKWETFLTSELPGWLQANR 8 A,B,C 46 16 3 
     LC-MS/MS  ASDMWGPKEDPAWQR 6 A,B 26 18 3 
Rv3835 40.76/- 34 5.06/- 4.91 MS 10/23%  A 70 51  
Rv3841 20.44 20 4.73 4.81 MS/MS 1 AGANLFELENFVAR  A 88 51 1 
Rv3846 23.3  5.96  LC-MS/MS 3 YAAATSQTK 10 A 59 22 2 
     LC-MS/MS  AKEDHSAILLNEK 10 A 42 21 3 
     LC-MS/MS  NLSPNGGDKPTGELAAAIADAFGSFDKFR 6 A 49 20 4 
Rv3849 14.71 9 8.82 5.7 MS 5/45%  A 52 51  
Rv3872 9.27  3.95  LC-MS/MS 1 AGEAVQDVAR 7 A 50 45 2 
Rv3874 10.79 10 4.59 4.5 MS  6/67%  A 55 51  
     LC-MS/MS  ADEEQQQALSSQMGF 10 A 56 22 2 
     LC-MS/MS  AEMKTDAATLAQEAGNFER 9 A,C 47 25 2 
     LC-MS/MS  FQEAANK 10 A 27 22 2 
     LC-MS/MS  GAAGTAAQAAVVR 10 A 42 23 2 
     LC-MS/MS  ISGDLK 10 A 24 24 2 
     LC-MS/MS  QAGVQYSR 10 A 42 23 2 
     LC-MS/MS  QELDEISTNIR 10 A 49 42 2 
     LC-MS/MS  QKQELDEISTNIR 9 A,C 49 42 2 
     LC-MS/MS  TDAATLAQEAGNFER 10 A,B,C 47 25 2 
     LC-MS/MS  TQIDQVESTAGSLQGQWR 9 A,B 61 41 3 
     MS/MS  TQIDQVESTAGSLQGQWR  A 114 51 1 
Rv3875 9.9 9 4.48 4.25 MS/MS 2 WDATATELNNALQNLAR  A 75 51 1 
     LC-MS/MS  WDATATELNNALQNLAR 10 A,B 38 26 2 
     LC-MS/MS  LAAAWGGSGSEAYQGVQQK 10 A 67 41 2 
Rv3881c 47.59 60 4.75 4.55 MS  10/39%  A 124 76  
     LC-MS/MS 10 ANEVEAPMADPPTDVPITPCELTAAK 5 A 22 20 3 
     LC-MS/MS  DQILPVYAEYQQR 6 A,C 63 21 2 
     LC-MS/MS  EHPTYEDIVGLER 5 A,C 26 22 2 
     LC-MS/MS  EYLAAGAK 7 A 43 23 2 
     LC-MS/MS  EAAALSGDVAVK 3 A 46 22 2 
     LC-MS/MS  LYAENPSAR 6 A 39 23 2 
     LC-MS/MS  TQSQTVTVDQQEILNR 5 A 97 22 2 
     LC-MS/MS  VATAGEPNFMDLK 6 A,C 30 21 2 
     LC-MS/MS  VLTEYNNK 6 A 32 22 2 
     LC-MS/MS  AALEPVNPPKPPPAIK 4 A,C 25 23 3 
Rv3899c -/36.08  -/5.72  LC-MS/MS 1 RDSLPR 2 C 16 13 1 
Rv3914 12.54 12 5.6 4.9 MS  4/39%  A 59 51  
     LC-MS/MS 5 ATDLTVAKLDVDTNPETAR 9 B 77 17 3 
     LC-MS/MS  MVAPVLEEIATER 9 A,B 61 18 2 
     LC-MS/MS  NFQVVSIPTLILFK 10 A,B,C 38 24 2 
     LC-MS/MS  ATDLTVAK 9 B 29 24 2 
     LC-MS/MS  NFQVVSIPTLILFKDGQPVK 10 B 48 19 3 
Rv3917c 34.63/34.46  5.96/6.12  LC-MS/MS 1 SLAGSQTGVRYQIVMGER 3 A 15 13 3 
MT0066,1 a 9.02/9.02 13.7 4.20/4.20 4 MS/MS 1 WGFGDLAVCDGEK  A 58 51 1 
MT2420 a 10.00 10 4.97 4.6 MS/MS 1 AQAAALEAEHQAIVR  A 131 51 1 
MT3437,1 a 17.35 9 11.07 5.18 MS 7/41%    A 52 51  
 
 
aGene number as annotated for M. tuberculosis H37Rv (Rv) or M. tuberculosis CDC1551 (MT).  Three proteins were only identified with the 
annoted genes for M. tuberculosis CDC1551. The nucleotide sequence of MT0066.1 is identical in M. tuberculosis H37Rv and found in positions 
65012..65392 on the minus (-) strand overlapping with Rv0061 which is annotated as a conserved hypothetical protein (questionable ORF).  The 
sequence of the peptide identified to belong to MT2420 is not encoded in the M. tuberculosis H37Rv genome. The peptide is highly homologous to a 
peptide found in Rv1793, the only difference being an A in MT2420 instead of an S. The peptide may therefore be derived from Rv1793 being 
modified posttranslationally by removal of a hydroxyl group to change S to A. The nucleotide sequence of MT3437.1 is identical in M. tuberculosis 
H37Rv and found in positions 3720757..3721236 on the plus (+) strand overlapping slightly with Rv3333c (position 3720782), extending in the gap 
between this gene and Rv3334 which starts at position 3721257. 
bTheoretical molecular mass (kDa) or isoelectric point (pI) calculated after removing the predicted signal peptide as determined by prediction of 
lipoprotein consensus motif using Compute pI/MW tool, publicly available at (http://au.expasy.org/tools/pi_tool.html). See also supplementary table 
2. 
cTheoretical molecular mass (kDa) calculated after removing the predicted signal peptide by Neural Network/Hidden Markov model, using Compute 
pI/MW tool, publicly available at (http://au.expasy.org/tools/pi_tool.html). Only one figure is given when the predictions were concordant. If one of 
the methods did not predict a signal peptide it is designated with a “-“. See also supplementary table 2. 
dObserved molecular masses as determined by 2D-PAGE. 
eTheoretical isoelectric point (pI) calculated after removing the predicted signal peptide by Neural Network/Hidden Markov model, Compute pI/MW 
tool, publicly available at (http://au.expasy.org/tools/pi_tool.html). If one of the methods did not predict a signal peptide it is designated with a “-“. 
See also supplementary table 2. 
fObserved pI as determined by 2D-PAGE.  
gPeptides were identified by Matrix-assisted laser desorption ionization time-of-flight mass spectrometry of spots collected from 2D-PAGE (MS), 
Matrix-assisted laser desorption ionization time-off-flight mass spectrometry combined with tandem mass spectrometry (MS/MS) or Liquid 
chromatography Electrospray Ionisation  with tandem mass spectrometry (LC- MS/MS) 
hNone of the identified peptides by MS or MS/MS were predicted signal peptides, 
iSequence coverage for individual proteins is given as number of peptides/percentage of sequence coverage for MS data, or as number of identified 
peptides for MS/MS and LC-MS/MS data. 
j Fraction number of identified peptide after SDS-PAGE performed as shown in Figure 2. Explanation of the fraction numbers: (1) >160 kDa, (2) 
ranges from 105-160 kDa, (3) ranges from 75-105 kDa, (4) ) ranges from 50-75 kDa, (5) ranges from 35-50 kDa, (6) ranges from 30-35 kDa, (7) 
ranges from 25-30 kDa, (8) ranges from 15-25 kDa, (9) ranges from 15-10 kDa, (10) <10 kDa. Many peptides were observed several times and also 
in more than one fraction. In such cases the fraction with most observations or most reliable observation is given. 
k Batch number refers to the three different batches (A,B or C) of 3 - 4 week old M. tuberculosis H37Rv culture filtrates analysed. 
 
*    Two peptides identified by LC-MS/MS matched all of these proteins: EsxI (Rv1037c), EsxL (1198), EsxN (Rv1793), EsxO (Rv2346c)    
      and EsxV (Rv3619c),    
** One protein spot (Fig, 1, ¤) fingerprint matched all of these proteins: EsxJ (Rv1038c), EsxK (Rv1197), EsxP (Rv2347c) and EsxW  
            (Rv3620c) 
      *** One peptide identified by LC-MS/MS matched both EsxK (Rv1197) and EsxP (Rv2347c). 
 
Supplementary table 2. List of predicted secreted and exported proteins of M. tuberculosis H37Rv culture filtrate proteins identified in this 
study, with their possible retention peptides.  
 
Gene 
number 
 
Signal peptidea  
 
Signal 
peptidase 
Retention
signal 
Predicted localization 
 of protein 
Rv0012 MRLTHPTPCPENGETMIDRRRSAWRFSVPLVCLLAGLLLAATHGVSG↓GTE SPase Ic - Secreted protein 
Rv0019c MQGLVLQLTRAGFLMLLWVFIWSVLRILKTDIYAPTGAVMMRRGLALRGTLLGARQRRHA**ARY SPase I - Secreted protein 
Rv0040c MIQIARTWRVFAGGMATGFIGVVLVTAGKASA**DPLLPPPPIPAPVSAPA*TVP SPase I - Secreted protein 
Rv0063 MAREISRQTFLRGAAGALAAGAVFGSVRATA↓DPA f SPase I - Secreted protein 
Rv0116c MRRVVRYLSVVVAITLMLTAESVSIATA**AVPPLQPIPGVASVSPANG*AVV SPase I - Secreted protein 
Rv0125 MSNSRRRSLRWSWLLSVLAAVGLGLATAPAQA↓APP SPase I - Secreted protein 
Rv0129c MTFFEQVRRLRSAATTLPRRLAIAAMGAVLVYGLVGTFGGPATAGA↓FSR SPase I - Secreted protein 
Rv0164 MTAISCSPRPRYASRMPVLSKTVEVTADA**ASI SPase I - Secreted protein 
Rv0170 MKITGTVVKLGIVSVVLLFFTVMIIVIFG*QMR**FDR SPase I - Secreted protein 
Rv0172 MSTIFDIRNLRLPQLSRASVVIGSLVVVLALA**AG*IVG SPase I - Secreted protein 
Rv0174 MLTRFIRRQLILFAIVSVVA**IVVLG*WYY SPase I - Secreted protein 
Rv0203 MKTGTATTRRRLLAVLIALALPGAAVALLAEPSATG*A**SDP SPase I - Secreted protein 
Rv0285 MTLRVVPEGLAAASAAVEALTARLAAAHASA↓APV SPase I - Secreted protein 
Rv0309 MSRLLALLCAAVCTGCVAVVLAPVSLAVVNPWFA**NSVGN*ATQ SPase I - Secreted protein 
Rv0315 MLMPEMDRRRMMMMAGFGALAAALPAPTAWA**DPSRPAAPAGPTPAPAAPA*AAT SPase I - Secreted protein 
Rv0398c MGVIARVVGVAACGLSLAVLAAAPTAGA↓EPT SPase I - Secreted protein 
Rv0453 MTSALIWMASPPEVHSALLSSGPGPGPVLA*AAT SPase I - Secreted protein 
Rv0455c MSRLSSILRAGAAFLVLGIAAATFPQSAAA↓DST SPase I - Secreted protein 
Rv0477 MKALVAVSAVAVVALLGVSSAQA↓DPE SPase I - Secreted protein 
Rv0490 MTVFSALLLAGVLSALALAVGG↓AVG SPase I - Secreted protein 
Rv0506 MRMISVSGAVKRMWLLLAIVVVA**VVGGLGIYR*LHS SPase I - Secreted protein 
Rv0559c MKGTKLAVVVGMTVAAVSLAAPAQA↓DDY SPase I - Secreted protein 
Rv0674 MPAMTARSVVLSVLLGAHPAWA↓TAS SPase I - Secreted protein 
Rv0677c MIGTLKRAWIPLLILVVVAIA**GFTVQRIRTFFGSEGILVTPKVFA*DDP SPase I - Secreted protein 
Rv0774c MPIRPNVHGMMARMPELSRRAVLGLGAGTVLGATSAYAIDM*LLQPRTSHAAPAAAIGTNVPLAPTPA**LDP SPase I - Secreted protein 
Rv0787 MHRPPWLAQLRRRLRIGVQL**GSR SPase I - Secreted protein 
Rv0851 MDGFPGRGAVITGGASGIGLATGTEFA*RRG SPase I - Secreted protein 
Rv0867c MSGRHRKPTTSNVSVAKIAFTGAVLGGGGIAMA**AQATA*ATD SPase I - Secreted protein 
Rv0982 MWWFRRRDRAPLRATSSLSLRWRVMLLAMSMVAMVVVLMSFAVYAVISA↓ALY SPase I - Secreted protein 
Rv1050 MARQRFRDQVVLITGASSGIGEATAKAFA*REG SPase I - Secreted protein 
Rv1075c MPRRSTIALATAGALASTGTA**YLGARNLLVGQATHA*RTV SPase I - Secreted protein 
Rv1158c MPTIWTFVRAASSAALLTGGIAHA**DPAPAPAPAPNIPQQLISSAANAPQILQNLATALG*ATP SPase I - Secreted protein 
Rv1174c MRLSLTALSAGVGAVAMSLTVGAGVASA↓DPV SPase I - Secreted protein 
Rv1269c MTTMITLRRRFAVAVAGVATAAATTVTLAPAPANA↓ADV SPase I - Secreted protein 
Rv1352 MARTLALRASAGLVAGMAMAAITLAPGARA↓ETG SPase I - Secreted protein 
Rv1382 MNSGTLAGSLIFAAVLVMLIAVLA*RLMMRGWRRR**SER SPase I - Secreted protein 
Rv1386 MTLRVVPESLAGASAAIEAVTARLAAAHA*AAPFIA**AVI SPase I - Secreted protein 
Rv1419 MGELRLVGGVLRVLVVVGAVFDVAVLNAGAASA↓DGP SPase I - Secreted protein 
Rv1435c MTLMAIVNRFNIKVIAGAGLFAAAIALSPDAAA↓DPL SPase I - Secreted protein 
Rv1477 MRRNRRGSPARPAARFVRPAIPSALSVALLVCTPGLATA↓DPQ SPase I - Secreted protein 
Rv1488 MQGAVAGLVFLAVLVIFAIIVVAKSVALIPQAEA↓AVI SPase I - Secreted protein 
Rv1759c MSFVIAVPETIAAAATDLADLGSTIAGANAAAA*ANT SPase I - Secreted protein 
Rv1804c MRVVSTLLSIPLMIGLAVPAHA↓GPS SPase I - Secreted protein 
Rv1810 MQLQRTMGQCRPMRMLVALLLSAATMIGLAAPGKA↓DPT SPase I - Secreted protein 
Rv1812c MTRVVVIGSGFAGLWAALGA**A*RRL SPase I - Secreted protein 
Rv1815 MVRLVPRAFAATVALLAAGFSPATASA↓DPV SPase I - Secreted protein 
Rv1860 MHQVDPNLTRRKGRLAALAIAAMASASLVTVAVPATANA**DPEPAPPVPTTAASPPSTAAA*PPA SPase I - Secreted protein 
Rv1869c MASSTTFVIVGGGLAGA*KAVEA**LRR SPase I - Secreted protein 
Rv1884c MHPLPADHGRSRCNRHPISPLSLIGNASATSGDMSSMTRIAKPLIKSAMAAGLVTASMSLSTAVAHA**GPS SPase I - Secreted protein 
Rv1886c MTDVSRKIRAWGRRLMIGTAAAVVLPGLVGLAGGAATAGA↓FSR SPase I - Secreted protein 
Rv1891 MIRELVTTAAITGAAIGGAPVAGA*DPQ SPase I - Secreted protein 
Rv1906c MRLKPAPSPAAAFAVAGLILAGWAGSVGLAGA↓DPE SPase I - Secreted protein 
Rv1910c MAHAFHRFALAILGLALPVALV**AYGGNGDSRKA*APL SPase I - Secreted protein 
Rv1926c MKLTTMIKTAVAVVAMAAIATFAAPVALA↓AYP SPase I - Secreted protein 
Rv1980c MRIKIFMLVTAVVLLCCSGVATA↓APK SPase I - Secreted protein 
Rv1984c MTPRSLVRIVGVVVATTLALVSAPAGGRA**AHA*DPC SPase I - Secreted protein 
Rv2190c MRLDQRWLIARVIMRSAIGFFASFTVSSGVLAANVLA↓DPA SPase I - Secreted protein 
Rv2201 MCGLLAFVAAPAGAAGPEGADA↓ASA SPase I - Secreted protein 
Rv2251 MRWRASSAPSISAPPIATGCCTPA*ASPPQTCCGAKTPVSRMRPTRCCCPAAPTGEDA**VAD SPase I - Secreted protein 
Rv2253 MSGHRKKAMLALAAASLAATLAPNAVA**A*AEP SPase I - Secreted protein 
Rv2301 MNDLLTRRLLTMGAAAAMLAAVLLLTPITVPAGYPGAVAPATA**ACPDAEVVFAR*GRF SPase I - Secreted protein 
Rv2376c MKMVKSIAAGLTAAAAIGAAAA**GVTSIMAGGPVVYQMQPVVFGAPLPLDPASA*PDV SPase I - Secreted protein 
Rv2450c MKNARTTLIAAAIAGTLVTTSPAGIANA↓DDA SPase I - Secreted protein 
Rv2469c MAHGKKRRGHRSSGVAAGVTGPASC**LHSVHSHR*LAS SPase I - Secreted protein 
Rv2576c MPAGVGNASGSVLDMTSVRTVPSAVALVTFAGAALSGVIPAIARA↓DPV SPase I - Secreted protein 
Rv2668 MRHWLIVLATLLVAAAGVAAA**NDVPRAWA*GDA SPase I - Secreted protein 
Rv2766c MTSLDLTGRTAIITGASRGIGLAIAQQLAA*AGAHVVLTARRQEA**ADE SPase I - Secreted protein 
Rv2799 MYTPGKGPPRAGGVVFTRVRLIGGLGALTA**AVVVVGTVGWQGIPPAPTGGDAVQLRSTA*APM SPase I - Secreted protein 
Rv2848c MRVSAVAVAAPASGSG*KTTIATGLIGALRQA**GHT SPase I - Secreted protein 
Rv2875 MKVKNTIAATSFAAAGLAALAVAVSPPAAA↓GDL SPase I - Secreted protein 
Rv2878c MSLRLVSPIKAFADGIVAVAIAVVLMFGLANTPRAVA↓ADE SPase I - Secreted protein 
Rv3004 MAHFAVGFLTLGLLVPVLTWPVSAPLLVIPVALS*ASIIRLRTLA**DER SPase I - Secreted protein 
Rv3033 MAHSIVRTLLASGAATALIAIPTACSFSIGTSHSHSVSKA↓EVA SPase I - Secreted protein 
Rv3036c MRYLIATAVLVAVVLVGWPAAGA**PPSCAGLGGTVQA*GQI SPase I - Secreted protein 
Rv3106 MRPYYIAIVGSGPSAFFAAASLLKA↓ADT SPase I - Secreted protein 
Rv3158c MILPAPHVEYFLLAPMLIVFSVAVAGVLAEA*FLPRRWRYGAQVTLALGGSAVALIAVIVVARS**IHG SPase I - Secreted protein 
Rv3194c MNRRILTLMVALVPIVVFGVLLAVVTVPFVA**L*GPG SPase I - Secreted protein 
Rv3201 MTQTAAPARYSPAELACALGLFPPTAEQAAVIAAPPGPLVVIAGA↓GAG SPase I - Secreted protein 
Rv3267 MMSAQRVVRTVRTARAISTALAVAIVLGTGVA**WS*SVR SPase I - Secreted protein 
Rv3310 MLRGIQALSRPLTRVYRALAVIGVLAASLLASWVGA**VPQVGLAASA*LPT SPase I - Secreted protein 
Rv3354 MNLRRHQTLTLRLLAASAGILSAAAFAAPAQA↓NPV SPase I - Secreted protein 
Rv3402 MKIRTLSGSVLEPPSAVRA*TPG SPase I - Secreted protein 
Rv3484 MARSEGNRPRHRAVPQPSRIRKRLSRGVMTLVSVVALLMTGAGY**WVAHGALGGITISQA*LTP SPase I - Secreted protein 
Rv3485c MNSRAPRNLAVSSPSAQVTGR**MVQ SPase I - Secreted protein 
Rv3491 MNIRCGLAAGAVICSAVALGIALHSGDPARA↓LGP SPase I - Secreted protein 
Rv3572 MTRLIPGCTLVGLMLTLLPAPTSA**A*GSN SPase I - Secreted protein 
Rv3587c MLDLEPRGPLPTEIYWRRRGLALGIAVVVVGIAVAIVIAFVDSSAGA↓KPV SPase I - Secreted protein 
Rv3627c MGPTRWRKSTHVVVGAAVLAFVAVVVAAA**ALVTTGGHRAGVRAPAPPPRPPTVKA*GVV SPase I - Secreted protein 
Rv3682 MPERLPAAITVLKLAGCCLLASVVATA**LTFPFAGGLGLMSNR*ASE SPase I - Secreted protein 
Rv3693 MILTGRTGLLALICVLPIALSPWPARAFVMLLVALAVAVTVDTLLA↓AST SPase I - Secreted protein 
Rv3705c MRIAAAVVSIGLAVIAGFAVPVADA↓HPS SPase I - Secreted protein 
Rv3725 MQNATMRVLVTGGTGFVGGWTAKAIA*DAG SPase I - Secreted protein 
Rv3803 MKGRSALLRALWIAALSFGLGGVAVA**AEPTAKA*APY SPase I - Secreted protein 
Rv3804 MQLVDRVRGAVTGMSRRLVVGAVGAALVSGLVGA**VGGTATAGA*FSR SPase I - Secreted protein 
Rv3835 MLDAPEQDPVDPGDPASPPHGEAEQPLPGPRWPRALRASATRRALLLTALGGLLIAGLVTA**IPA SPase I - Secreted protein 
Rv3899c MVTGQPAAAGAHSLSEGAMTAMQSGSVPPPQATPPITTPPVVSAPTMAAG*IEA SPase I - Secreted protein 
Rv3917c MTQPSRRKGGLGRGLAALIPTGPA**DG*ESG SPase I - Secreted protein 
MT0066.1 MESAESIQRLTEFEMKLKFARLSTAILGCAAALVFPASVASA↓DPP SPase I - Secreted protein 
Rv0015c MSPRVGVTLSGRYRLQRLIA**TGG SPase I 1 TMe Transmembrane protein 
Rv0062 MTRRTGQRWRGTLPGRRPWTRPAPATCRRHLAFVELRHYFARVMSSAIGSVARWIVPLLGVAAVA**SIG SPase I 1 TM Transmembrane protein 
Rv0064 METGSPGKRPVLPKRARLLVTAGMGMLALLLFGPRLV**DIYV*DWL SPase I 6 TM Transmembrane protein 
Rv0219 MFDIATRFKNSYGSGPLHLLAMVSGFALLGYIVATA↓RPS SPase I 4 TM Transmembrane protein 
Rv0291 MIRAAFACLAATVVVAGWWTPPAWA**IGPIGPPVVDAAA*QPP SPase I 1 TM Transmembrane protein 
Rv0402c MRSQRLAGHLSAAARTIHALSLPIILFWVALTIVVNVVA**PQLQSVAR*THS SPase I 11 TM Transmembrane protein 
Rv0436c MIGKPRGRRGVNLQILPSAMTVLSICAGLTAIKFA**LEHQPKAAMALIAAA*AIL SPase I 4 TM Transmembrane protein 
Rv0446c MVTSVSALAVAVVHSVAFA↓IGR SPase I 4 TM Transmembrane protein 
Rv0563 MTWHPHANRLKTFLLLVGMSALIVAVGALFGRTALMLA**ALFA*VGM SPase I 4TM Transmembrane protein 
Rv0680c MKWNTVAASLAAGVITIAVALAAPPPAAHA↓KNG SPase I 1 TM Transmembrane protein 
Rv0732 MLSAFISSLRTVDLRRKILFTLGIVILYRVGAA**LPSPGVNFPNVQQCIKEASA*GEA SPase I 8 TM Transmembrane protein 
Rv0996 MPSIPQSLLWISLVVLWLFVLVPMLISKR*DA**VVR SPase I 2 TM Transmembrane protein 
Rv1183 MVGCWVALALVLPMAVPSLAEMA**QR*HPV SPase I 10 TM Transmembrane protein 
Rv1845c MSALAFTILAVLLAGPTPALLA*RATWPLRAPRAAMVLWQAIALAAVLSSFSA**GIA SPase I 4 TM Transmembrane protein 
Rv2060 MLTVVCLLVVTVLAICYRPLLFATVDPEVAAA*RGVPVRALGIVFAALMGVVAAQA**VQI SPase I 3 TM Transmembrane protein 
Rv2200c MTPRGPGRLQRLSQCRPQRGSGGPARGLRQLALAAMLGALAVTVSGCSWS*EA**LGI SPase I 3TM Transmembrane protein 
Rv2563 MLFAALRDVQWRKRRLVIAIVSTGLVFAMTLVLTGLVNGFR*VEA**ERT SPase I 4 TM Transmembrane protein 
Rv2693c MNANRTSAQRLLAQAGGVSGLVYSSLPVVTFVVASSA*AGLLPAIGFALSMAGLILLWRLLRRESA**RPV SPase I 5 TM Transmembrane protein 
Rv2721c MNGQRGQLSTLIGRTLLGLAATAVTAVLLAPTVAA↓SPM SPase I 1 TM Transmembrane protein 
Rv2874 MVESRRAAAAASAYASRCGIAPATSQRSLA↓TPP SPase I 4 TM Transmembrane protein 
Rv2994 MSRDPTGVGARWAIMIVSLGVTASSFLFINGVAF**LIPRLENA*RGT SPase I 7 TM Transmembrane protein 
Rv3193c MGMRSAARMPKLTRRSRILIMIALGVIVLLLAGPRLIDA↓YVD SPase I 6 TM Transmembrane protein 
Rv3629c MSTFRIFGFSLLMTVVALVTGYLHG*GPTALFLLAVLALLEVSLSFDNA**IIA SPase I 9 TM Transmembrane protein 
Rv3671c MTPSQWLDIAVLAVAFIAAISGWRAGALGSMLSFGGVLLGATA**GVL SPase I 3 TM Transmembrane protein 
Rv3760 MPGSVPGKAPEEPPVKFTRAAAVWSALIVGFLILILLLIFIAQNTASA↓QFA SPase I 3 TM Transmembrane protein 
Rv0526 MQSRATRRSGALTMRRLVIAAAVSALLLTG↓↓CSGRDAVA*QGG**DAV SPase I/II Lipid Secreted protein / Surface lipoprotein 
Rv0999 MRPPLAPQFAADLLVKTVSTLRSSGAAGRLTTMRKAVLAVGSVCWLVG↓↓CSSGASS**TTA*STG SPase I/II Lipid Secreted protein / Surface lipoprotein 
Rv2911 MRKLMTATAALCA↓↓CAVTVSAGA**AWA*DAD SPase I/II Lipid Secreted protein / Surface lipoprotein 
Rv3668c MQTAHRRFAAAFAAVLLAVV↓↓CLPANTAAA↓DDK SPase I/II Lipid Secreted protein / Surface lipoprotein 
Rv3759c MRMLRRLRRATVAAAVWLATVCLVAS↓↓CANA↓DPL SPase I/II Lipid Secreted protein / Surface lipoprotein 
Rv0173 MMSVLARMRVMRHRAWQGLVLLVLALLLSS↓↓CGW SPase IId Lipid Surface lipoprotein 
Rv0237 MAFPRTLAILAAAAALVVA↓↓CSH SPase II Lipid Surface lipoprotein 
Rv0265c MRQGCSRRGFLQVAEAAAATGLFAG↓↓CSS SPase II Lipid Surface lipoprotein 
Rv0411c MTRRALLARAAAPLAPLALAMVLAS↓↓CGH SPase II Lipid Surface lipoprotein 
Rv0583c MKHFTAAVATVALSLALAG↓↓CSF SPase II Lipid Surface lipoprotein 
Rv0835 MCCSTAAKSAVIVCCAAIATTA↓↓CSF SPase II Lipid Surface lipoprotein 
Rv0838 MRLIGRLRLLMVGLVVICGACA↓↓CDR SPase II Lipid Surface lipoprotein 
Rv0928 MKLNRFGAAVGVLAAGALVLSA↓↓CGN SPase II Lipid Surface lipoprotein 
Rv0932c MKFARSGAAVSLLAAGTLVLTA↓↓CGG SPase II Lipid Surface lipoprotein 
Rv0934 MKIRLHTLLAVLTAAPLLLAAAG↓↓CGS SPase II Lipid Surface lipoprotein 
Rv1166 MGVPSPVRRVCVTVGALVALACMVLAG↓↓CTV SPase II Lipid Surface lipoprotein 
Rv1252c MPGVWSPPCPTTPRVGVVAALVAATLTG↓↓CGS SPase II Lipid Surface lipoprotein 
Rv1270c MKHPPCSVVAAATAILAVVLAIGG↓↓CST SPase II Lipid Surface lipoprotein 
Rv1541c MRWIGVLVTALVLSA↓↓CAA SPase II Lipid Surface lipoprotein 
Rv1899c MSRAAGLPRLSWFAGLTWFAGGSTGAG↓↓CAA SPase II Lipid Surface lipoprotein 
Rv1911c MTSTLHRTPLATAGLALVVALGG↓↓CGG SPase II Lipid Surface lipoprotein 
Rv2068c MRNRGFGRRELLVAMAMLVSVTG↓↓CAR SPase II Lipid Surface lipoprotein 
Rv2080 MPHSTADRRLRLTRQALLAAAVVPLLAG↓↓CAL SPase II Lipid Surface lipoprotein 
Rv2224c MGMRLSRRDKIARMLLIWAALAAVALVLVG↓↓CIR SPase II Lipid Surface lipoprotein 
Rv2544 MIAPQPIPRTLPRWQRIVALTMIGISTALIGG↓↓CTM SPase II Lipid Surface lipoprotein 
Rv2585c MAPRRRRHTRIAGLRVVGTATLVAATTLTA↓↓CSG SPase II Lipid Surface lipoprotein 
Rv2672 MATVVGMSRPMTSTAMLVALTCSATVLAA↓↓CVP SPase II Lipid Surface lipoprotein 
Rv2873 MINVQAKPAAAASLAAIAIAFLAG↓↓CSS SPase II Lipid Surface lipoprotein 
Rv2905 MRARPLTLLTALAAVTLVVVAG↓↓CEA SPase II Lipid Surface lipoprotein 
Rv2945c MNDGKRAVTSAVLVVLGA↓↓CLA SPase II Lipid Surface lipoprotein 
Rv3006 MWTTRLVRSGLAALCAAVLVSSG↓↓CAR SPase II Lipid Surface lipoprotein 
Rv3016 MVGLTRPLLLCGATLLIAA↓↓CTR SPase II Lipid Surface lipoprotein 
Rv3044 MRSTVAVAVAAAVIAASSG↓↓CGS SPase II Lipid Surface lipoprotein 
Rv3244c MRLTILLFLGAVLAG↓↓CAS SPase II Lipid Surface lipoprotein 
Rv3495c MNRIWLRAIILTASSALLAG↓↓CQF SPase II Lipid Surface lipoprotein 
Rv3584 MNRCNIRLRLAGMTTWVASIALLAAALSG↓↓CGA SPase II Lipid Surface lipoprotein 
 
a  Sec-type signal peptides were identified by using SignalP, publicly available at (http://www.cbs.dtu.dk/services/SignalP-3.0/).  
↓  Signal peptidase I cleavage site concordantly predicted by Neural Network method and Hidden Markov model.  
*   Signal peptidase I cleavage site predicted only by Hidden Markov Model. 
** Signal peptidase I cleavage site predicted only by Neural Network. 
↓↓ Predicted Signal peptidase II cleavage sites. Lipoprotein signal peptides were identified by Lipo-tool, which is publicly available at 
(http://www.bioinfo.no/tools/lipo) or by using the ProSite PS00013 lipoprotein concensus motif. 
b Identified export signals are Sec-type signal peptides (Sec), and lipoprotein signal peptides (Lipo). 
c Signal peptidase I 
d Signal peptidase II 
e Transmembrane (TM) domains present in the mature part of the protein after processing by the Signal peptidase. 
f The first 3 amino acids of verified mature sequences are underlined. See also table 2. 
